| placebo |
placebo |
169 |
2014 |
| Drug |
clopidogrel |
88 |
2010 |
| Drug |
aspirin |
54 |
2014 |
| Drug |
ticagrelor |
46 |
2014 |
| Drug |
atorvastatin |
28 |
2014 |
| Procedure |
percutaneous coronary intervention |
27 |
2014 |
| Drug |
prasugrel |
27 |
2011 |
| Drug |
ezetimibe |
22 |
2014 |
| Other |
standard care |
21 |
2017 |
| Drug |
regadenoson |
18 |
2009 |
| Drug |
rosuvastatin |
14 |
2009 |
| Behavioral |
exercise training |
13 |
2010 |
| Drug |
saline |
12 |
2013 |
| Other |
exercise |
11 |
2018 |
| Procedure |
pci |
11 |
2014 |
| Drug |
simvastatin |
10 |
2018 |
| Drug |
adenosine |
9 |
2010 |
| Drug |
heparin |
9 |
2018 |
| Drug |
metformin |
9 |
2016 |
| Device |
bare metal stent |
8 |
2009 |
| Procedure |
cabg |
8 |
2010 |
| Other |
control |
8 |
2010 |
| Device |
drug-eluting stent |
8 |
2017 |
| Device |
drug eluting stent |
8 |
2009 |
| Drug |
propofol |
8 |
2019 |
| Device |
xience |
8 |
2017 |
| Procedure |
coronary angiography |
7 |
2017 |
| Drug |
ranolazine |
7 |
2015 |
| Drug |
abt-335 |
6 |
2008 |
| Device |
coronary stent |
6 |
2010 |
| Device |
cypher |
6 |
2009 |
| Drug |
ivabradine |
6 |
2017 |
| Drug |
niacin |
6 |
2013 |
| Procedure |
percutaneous coronary intervention (pci) |
6 |
2014 |
| Procedure |
remote ischemic preconditioning |
6 |
2010 |
| Drug |
cilostazol |
5 |
2014 |
| Drug |
colchicine |
5 |
2020 |
| Device |
everolimus-eluting stent |
5 |
2010 |
| Device |
ffr |
5 |
2010 |
| Device |
ivus |
5 |
2014 |
| Device |
orsiro |
5 |
2015 |
| Drug |
pioglitazone |
5 |
2009 |
| Drug |
sevoflurane |
5 |
2019 |
| Device |
sirolimus-eluting stent |
5 |
2013 |
| Device |
stent |
5 |
2011 |
| Procedure |
stenting |
5 |
2013 |
| Drug |
bivalirudin |
4 |
2013 |
| Drug |
cangrelor |
4 |
2013 |
| placebo |
comparator: ezetimibe, placebo |
4 |
2004 |
| Procedure |
coronary artery bypass grafting |
4 |
2018 |
| Device |
coronary artery stenting |
4 |
2017 |
| Device |
cypher select |
4 |
2010 |
| Device |
cypher sirolimus-eluting stent |
4 |
2007 |
| Drug |
dalcetrapib |
4 |
2011 |
| Behavioral |
diet, fat-restricted |
4 |
1999 |
| Device |
drug eluting balloon |
4 |
2009 |
| Biological |
evolocumab |
4 |
2017 |
| Procedure |
forearm vascular study |
4 |
2009 |
| Other |
intervention |
4 |
2018 |
| Drug |
mk0653, ezetimibe |
4 |
2004 |
| Device |
paclitaxel-eluting stent |
4 |
2013 |
| Drug |
pb127 for injectable suspension |
4 |
2008 |
| Drug |
remifentanil |
4 |
2019 |
| Device |
resolute integrity stent |
4 |
2012 |
| Drug |
rvx000222 |
4 |
2011 |
| Drug |
sitagliptin |
4 |
2014 |
| Behavioral |
smoking cessation |
4 |
2007 |
| Drug |
statin |
4 |
2019 |
| Drug |
thienopyridine |
4 |
2011 |
| Drug |
ticagrelor 180mg |
4 |
2014 |
| Drug |
ticagrelor 90mg |
4 |
2014 |
| Drug |
valsartan |
4 |
2009 |
| Drug |
xenon |
4 |
2010 |
| Device |
xience vâ® everolimus eluting coronary stent |
4 |
2006 |
| Device |
absorb bvs |
3 |
2014 |
| Drug |
acarbose |
3 |
2009 |
| Drug |
acetylsalicylic acid |
3 |
2013 |
| Other |
aerobic exercise training |
3 |
2012 |
| Drug |
amlodipine |
3 |
2010 |
| Device |
angiography |
3 |
2018 |
| Drug |
aspirin monotherapy |
3 |
2010 |
| Drug |
aspirin,clopidogrel |
3 |
2010 |
| Drug |
ateronon |
3 |
2009 |
| Device |
bare-metal stent |
3 |
2010 |
| Procedure |
blood sample |
3 |
2007 |
| Behavioral |
cardiac rehabilitation |
3 |
2009 |
| Drug |
celecoxib |
3 |
2007 |
| Biological |
cells |
3 |
2018 |
| Dietary Supplement |
coenzyme q10 |
3 |
2010 |
| Dietary Supplement |
control diet |
3 |
2014 |
| Procedure |
coronary artery bypass graft surgery |
3 |
2011 |
| Device |
coronary intervention |
3 |
2013 |
| Procedure |
coronary stenting |
3 |
2017 |
| Device |
ct-scan |
3 |
2018 |
| Device |
cypher sirolimus-eluting coronary stent |
3 |
2005 |
| Device |
cypher stent |
3 |
2010 |
| Drug |
dabigatran |
3 |
2013 |
| Drug |
dalcetrapib (ro4607381) |
3 |
2008 |
| Drug |
dipyridamole |
3 |
2011 |
| Device |
drug eluting coronary stent |
3 |
2006 |
| Other |
education |
3 |
2012 |
| Device |
endeavor |
3 |
2008 |
| Drug |
fenofibrate |
3 |
2016 |
| Behavioral |
health coaching |
3 |
2013 |
| Drug |
hormone replacement therapy |
3 |
1999 |
| Biological |
influenza vaccine |
3 |
2008 |
| Procedure |
invasive coronary angiography |
3 |
2020 |
| Behavioral |
lifestyle |
3 |
2011 |
| Behavioral |
lifestyle intervention |
3 |
2019 |
| Drug |
nitric oxide |
3 |
2018 |
| Drug |
nitroglycerin |
3 |
2016 |
| Drug |
ono-1101 |
3 |
2009 |
| Other |
optimal medical therapy |
3 |
2018 |
| Drug |
oxygen |
3 |
2014 |
| Device |
promus element |
3 |
2010 |
| Device |
promus element coronary stent system |
3 |
2011 |
| Device |
resolute onyxâ„¢ zotarolimus-eluting coronary stent system |
3 |
2018 |
| Drug |
rosuvastatin calcium |
3 |
2006 |
| Device |
sirolimus eluting stent |
3 |
2010 |
| Drug |
sufentanil |
3 |
2014 |
| Device |
synergy stent |
3 |
2016 |
| Device |
taxus libertã©-sr |
3 |
2006 |
| Device |
taxusâ„¢ express2â„¢ paclitaxel eluting coronary stent |
3 |
2006 |
| Drug |
tirofiban |
3 |
2011 |
| Drug |
tranexamic acid |
3 |
2012 |
| Drug |
vericiguat (bay1021189) |
3 |
2018 |
| Drug |
vitamin c |
3 |
1999 |
| Drug |
vitamin e |
3 |
1999 |
| Device |
xience v |
3 |
2009 |
| Behavioral |
NA |
2 |
2014 |
| Drug |
1 |
2 |
2011 |
| Drug |
12-month dapt |
2 |
2018 |
| Drug |
a-002 |
2 |
2007 |
| Drug |
abciximab |
2 |
2005 |
| Biological |
adalimumab |
2 |
2009 |
| Behavioral |
aerobic training |
2 |
2016 |
| Dietary Supplement |
aged garlic extract |
2 |
2019 |
| Procedure |
ai-700 contrast-enhanced echocardiography |
2 |
2005 |
| Drug |
alirocumab |
2 |
2018 |
| Drug |
aliskiren |
2 |
2009 |
| Dietary Supplement |
almonds |
2 |
2008 |
| Device |
amm fortitude bioresorbable drug-eluting coronary scaffold |
2 |
2014 |
| Device |
amplatzer vascular plug |
2 |
2019 |
| Device |
angiography guided pci |
2 |
2016 |
| Device |
angiography guided percutaneous coronary angioplasty with promus element stent implantation |
2 |
2013 |
| Device |
angioshield |
2 |
2015 |
| Drug |
apl180 |
2 |
2009 |
| Drug |
aspirin, clopidogrel |
2 |
2007 |
| Drug |
atorvastatin (lipitor) |
2 |
2007 |
| Drug |
atorvastatin 10 mg |
2 |
2007 |
| Drug |
atorvastatin 20 mg |
2 |
2007 |
| Drug |
atorvastatin calcium |
2 |
2007 |
| Drug |
azd5718 oral suspension |
2 |
2016 |
| Behavioral |
beating the blues (btb) |
2 |
2015 |
| Drug |
berberine |
2 |
2017 |
| Drug |
binodenoson |
2 |
2009 |
| Drug |
bradykinin receptor antagonist (hoe-140) |
2 |
2009 |
| Device |
buma supreme |
2 |
2016 |
| Drug |
caffeine |
2 |
2007 |
| Drug |
candesartan |
2 |
2008 |
| Procedure |
cardiac catheterization |
2 |
2011 |
| Device |
cardiac mri |
2 |
2014 |
| Drug |
closone |
2 |
2013 |
| Drug |
colestipol |
2 |
1999 |
| Drug |
contrast |
2 |
2018 |
| Procedure |
conventional cabg |
2 |
2018 |
| Procedure |
coronary angioplasty |
2 |
2016 |
| Procedure |
coronary angioplasty with stent implantation |
2 |
2014 |
| Procedure |
coronary computed tomography angiography |
2 |
2008 |
| Device |
coronary ct angiography |
2 |
2011 |
| Other |
coronary cta |
2 |
2011 |
| Device |
coronary pci guided by angiography |
2 |
2018 |
| Device |
coronary pci guided by oct |
2 |
2018 |
| Device |
coronary stent implantation |
2 |
2006 |
| Behavioral |
counseling |
2 |
2019 |
| Combination Product |
cswt |
2 |
2017 |
| Diagnostic Test |
ct angiography |
2 |
2020 |
| Other |
ct coronary angiography |
2 |
2011 |
| Procedure |
cto coronary angioplasty |
2 |
2016 |
| Drug |
custodiol |
2 |
2014 |
| Drug |
custodiol-n |
2 |
2014 |
| Drug |
dapagliflozin |
2 |
2016 |
| Behavioral |
decision aid |
2 |
2012 |
| Drug |
dexmedetomidine |
2 |
2019 |
| Other |
diagnostic cardiac imaging |
2 |
2012 |
| Behavioral |
diet |
2 |
2014 |
| Procedure |
endoscopic radial artery harvest |
2 |
2013 |
| Drug |
enoxaparin |
2 |
2014 |
| Drug |
escitalopram |
2 |
2007 |
| Drug |
estrogen replacement therapy |
2 |
1999 |
| Drug |
estrogens |
2 |
1999 |
| Drug |
etomidate |
2 |
2011 |
| Device |
everolimus eluting stent |
2 |
2010 |
| Drug |
ezetimibe 10 mg |
2 |
2007 |
| Drug |
fentanyl |
2 |
2016 |
| Diagnostic Test |
ffrct |
2 |
2017 |
| Drug |
fixed dose combination of clopidogrel |
2 |
2010 |
| Drug |
fixed dose combination of clopidogrel/aspirin |
2 |
2010 |
| Drug |
folic acid |
2 |
1999 |
| Device |
fractional flow reserve (ffr) |
2 |
2016 |
| Behavioral |
health education |
2 |
2018 |
| Other |
high-intensity interval training |
2 |
2011 |
| Device |
hybrid coronary revascularization |
2 |
2017 |
| Procedure |
hybrid revascularization |
2 |
2014 |
| Device |
icd implantation |
2 |
2009 |
| Device |
ifr |
2 |
2013 |
| Biological |
implantation |
2 |
2012 |
| Drug |
intensive insulin treatment |
2 |
2014 |
| Behavioral |
interactive education |
2 |
2006 |
| Other |
interval exercise training |
2 |
2014 |
| Other |
interval training |
2 |
2012 |
| Procedure |
intravascular ultrasound |
2 |
2008 |
| Drug |
iobitridol |
2 |
2010 |
| Drug |
ketamine |
2 |
2019 |
| Drug |
laropiprant |
2 |
2010 |
| Behavioral |
lifestyle counseling |
2 |
2013 |
| Drug |
liraglutide |
2 |
2014 |
| Device |
lithotripsy |
2 |
2018 |
| Drug |
lovastatin |
2 |
2005 |
| Drug |
lumason |
2 |
2015 |
| Other |
manual compression |
2 |
2011 |
| Drug |
medication |
2 |
2011 |
| Biological |
mesendo |
2 |
2008 |
| Drug |
methotrexate |
2 |
2008 |
| Drug |
methylprednisolone |
2 |
2005 |
| Dietary Supplement |
milk fat |
2 |
2011 |
| Drug |
mipomersen sodium |
2 |
2008 |
| Procedure |
mitral valve annuloplasty |
2 |
2018 |
| Behavioral |
moderate intensity continuous exercise training |
2 |
2016 |
| Drug |
moxifloxacin |
2 |
2018 |
| Drug |
n-acetyl cysteine |
2 |
2013 |
| Drug |
n-acetylcysteine |
2 |
2011 |
| Device |
neovas bcs |
2 |
2014 |
| Device |
neuromuscular electrical stimulation |
2 |
2018 |
| Drug |
nicorandil |
2 |
2011 |
| Device |
nirs |
2 |
2013 |
| Drug |
nitrous oxide |
2 |
2007 |
| Procedure |
no-touch vein harvesting technique |
2 |
2017 |
| Other |
no intervention |
2 |
2017 |
| Procedure |
no touch technique |
2 |
2018 |
| Behavioral |
nudge |
2 |
2019 |
| Device |
oct guided pci |
2 |
2017 |
| Device |
ofdi |
2 |
2013 |
| Device |
omt |
2 |
2010 |
| Device |
orbusneich combo stentâ„¢ |
2 |
2015 |
| Drug |
p2y12 antagonist |
2 |
2012 |
| Drug |
p2y12 inhibitor |
2 |
2017 |
| Behavioral |
peer support |
2 |
2006 |
| Device |
percutaneous coronary intervention (pci) with paclitaxel-eluting stent (taxus element) implantation |
2 |
2007 |
| Device |
pet |
2 |
2016 |
| Procedure |
pharmacologic case management |
2 |
2006 |
| Other |
physiotherapy |
2 |
2019 |
| Drug |
pitavastatin |
2 |
2009 |
| placebo |
placebo for influenza vaccine |
2 |
2008 |
| placebo |
placebo rvx000222 |
2 |
2011 |
| Dietary Supplement |
plant sterols |
2 |
2014 |
| Drug |
plavix with astrix |
2 |
2013 |
| Drug |
prasugrel 10 mg |
2 |
2010 |
| Drug |
prasugrel 5mg |
2 |
2017 |
| Drug |
prasugrel 60 mg |
2 |
2014 |
| Drug |
pravastatin |
2 |
2016 |
| Behavioral |
pre |
2 |
2016 |
| Drug |
progesterone |
2 |
2012 |
| Drug |
pz-128 |
2 |
2015 |
| Device |
rapamycin |
2 |
2008 |
| Biological |
red blood cell transfusion |
2 |
2016 |
| Other |
remote ischemic pre-conditioning |
2 |
2014 |
| Device |
resolute integrity |
2 |
2012 |
| Device |
resolute integrityâ„¢ zotarolimus-eluting coronary stent system |
2 |
2018 |
| Drug |
rivaroxaban |
2 |
2013 |
| Drug |
rocuronium |
2 |
2019 |
| Drug |
rosuvastatin calcium10mg |
2 |
2009 |
| Device |
rotational atherectomy |
2 |
2015 |
| Drug |
rubidium-82 |
2 |
2011 |
| Other |
same day discharge |
2 |
2013 |
| Drug |
sarpogrelate |
2 |
2014 |
| Device |
selective vagus nerve stimulation |
2 |
2009 |
| Other |
sham control |
2 |
2016 |
| Other |
sham procedure |
2 |
2014 |
| Drug |
simvastatin 20 mg |
2 |
2007 |
| Drug |
simvastatin 40 mg |
2 |
2007 |
| Other |
single photon emission computed tomography |
2 |
2011 |
| Device |
sirolimus-coated bx velocity stent |
2 |
2005 |
| Other |
spect |
2 |
2014 |
| Other |
standard cpb |
2 |
2018 |
| Drug |
standard medical therapy |
2 |
2016 |
| Behavioral |
standard risk assessment |
2 |
2013 |
| Procedure |
stress-mri |
2 |
2016 |
| Diagnostic Test |
stress cardiac mri |
2 |
2019 |
| Procedure |
stress echocardiography |
2 |
2015 |
| Drug |
sugar pill |
2 |
2012 |
| Device |
synergy |
2 |
2012 |
| Device |
taxus stent |
2 |
2008 |
| Device |
taxusâ„¢ express |
2 |
2006 |
| Behavioral |
text messaging |
2 |
2016 |
| Drug |
ticagrelor maintenance dose |
2 |
2014 |
| Diagnostic Test |
tomography angiography |
2 |
2017 |
| Behavioral |
training |
2 |
2007 |
| Behavioral |
transcendental meditation |
2 |
2015 |
| Procedure |
transit-time flowmetry |
2 |
2008 |
| Procedure |
ultrasound guidance |
2 |
2012 |
| Other |
ultrasound of aorta |
2 |
2013 |
| Device |
uncoated bx velocity balloon-expandable stent |
2 |
2007 |
| Drug |
vildagliptin |
2 |
2017 |
| Device |
virtual therapeutic support |
2 |
2019 |
| Drug |
vitamin b12 |
2 |
1999 |
| Drug |
warfarin |
2 |
2018 |
| Device |
xience primeâ„¢ |
2 |
2010 |
| Device |
xience v eecss |
2 |
2010 |
| Device |
xience vâ® |
2 |
2010 |
| Device |
xience vâ®/ xience primeâ„¢ |
2 |
2010 |
| Device |
zomaxxâ„¢ drug-eluting coronary stent system |
2 |
2005 |
| Device |
zotarolimus-eluting stent |
2 |
2010 |
| Device |
zotarolimus eluting stent |
2 |
2010 |
| Procedure |
‘spy’ nirf during cabg |
1 |
2014 |
| Procedure |
- percutaneous coronary intervention |
1 |
2019 |
| Behavioral |
“care4heart” programme |
1 |
2018 |
| Drug |
) ezetimibe |
1 |
2007 |
| Drug |
) simvastatin |
1 |
2005 |
| Other |
[11c]‑dmdpa |
1 |
2016 |
| Drug |
[3h] bms747158 |
1 |
2009 |
| Drug |
0.5 |
1 |
2012 |
| Drug |
0.9% nacl |
1 |
2012 |
| Drug |
1-month dapt |
1 |
2015 |
| Drug |
1-months dapt |
1 |
2018 |
| Drug |
1 month dapt |
1 |
2017 |
| Device |
1 stent |
1 |
2015 |
| Other |
1 week uv dosimeter |
1 |
2013 |
| Dietary Supplement |
1% milk |
1 |
2009 |
| Drug |
1.5 ml subcutaneous solution |
1 |
2019 |
| Drug |
1/10 na/ee |
1 |
2008 |
| Radiation |
1/2 dose of 99mtc/201tl tracers |
1 |
2011 |
| Drug |
10 na |
1 |
2008 |
| Drug |
12-month dual anti-platelet therapy |
1 |
2017 |
| Behavioral |
12-week risk reduction program, managed by a heart health educator |
1 |
2007 |
| Other |
12 months dual anti-platelet therapy |
1 |
2017 |
| Drug |
123i-cmice-013 |
1 |
2012 |
| Device |
17beta estradiolvalerat-eluting stent |
1 |
2006 |
| Drug |
18f-fluorodeoxyglucose |
1 |
2013 |
| Other |
18f-naf pet |
1 |
2015 |
| Other |
18f-naf pet/coronary cta imaging |
1 |
2015 |
| Radiation |
2 dose of 99mtc |
1 |
2011 |
| Device |
2 stents |
1 |
2015 |
| Drug |
20 mg |
1 |
2007 |
| Radiation |
201tl tracers |
1 |
2011 |
| Drug |
240 mg iodine |
1 |
2014 |
| Procedure |
3-dimensional coronary angiography |
1 |
2007 |
| Other |
3 months dual anti-platelet therapy |
1 |
2017 |
| Drug |
3 months of dual antiplatelet therapy (dapt) |
1 |
2015 |
| Drug |
300 mg iodine |
1 |
2014 |
| Dietary Supplement |
30g |
1 |
2018 |
| Procedure |
320 volume detector computed tomography |
1 |
2009 |
| Drug |
370 mg iodine |
1 |
2014 |
| Device |
38 mm) |
1 |
2017 |
| Other |
3t cmr |
1 |
2012 |
| Other |
4-day food diary |
1 |
2013 |
| Device |
4.0 cypher sirolimus-eluting coronary stent |
1 |
2005 |
| Device |
4r cardiac catheters |
1 |
2017 |
| Drug |
6-month dual anti-platelet therapy |
1 |
2017 |
| Drug |
6 months dapt |
1 |
2017 |
| Drug |
6% hydroxy ethyl starch |
1 |
2012 |
| Drug |
6% hydroxyethyl starch 200 |
1 |
2012 |
| Device |
64 channel vct |
1 |
2006 |
| Other |
68ga-nodaga-rgd pet |
1 |
2018 |
| Other |
68ga-nodaga-rgd pet/ct |
1 |
2018 |
| Device |
6f sheath |
1 |
2017 |
| Device |
6f sheath/guide catheter combination |
1 |
2017 |
| Drug |
7.2% nacl |
1 |
2012 |
| Drug |
7.2% nacl/6% hydroxyethyl starch 200/0.5 |
1 |
2012 |
| Device |
70% of sirolimus dose |
1 |
2005 |
| Device |
7f ensure medical vascular closure device |
1 |
2007 |
| Device |
7f sheathless guide catheter |
1 |
2017 |
| Diagnostic Test |
82-rb pet |
1 |
2018 |
| Diagnostic Test |
82-rb pet/ct as part of standard care, not a comparator |
1 |
2018 |
| Diagnostic Test |
99mtc-sestamibi |
1 |
2013 |
| Drug |
99mtechnicium (sestamibi |
1 |
2011 |
| Drug |
99mtechnicium (sestamibi/tetrofosmin) |
1 |
2011 |
| Genetic |
9p21 |
1 |
2012 |
| Other |
a-view |
1 |
2011 |
| Procedure |
a new non-invasive imaging technique |
1 |
2012 |
| Behavioral |
a nurse led home-based education |
1 |
2005 |
| Behavioral |
a nurse led home-based education/support programme |
1 |
2005 |
| Procedure |
aa |
1 |
2007 |
| Device |
abbott vascular absorb everolimus eluting bioresorbable vascular scaffold system |
1 |
2011 |
| Device |
abbott vascular xience everolimus eluting coronary stent system |
1 |
2011 |
| Device |
abbott xience family everolimus-eluting stent |
1 |
2015 |
| Device |
abbott xience v |
1 |
2008 |
| Device |
absorb |
1 |
2016 |
| Device |
absorb bvs system |
1 |
2013 |
| Device |
absorb bvsâ„¢ |
1 |
2013 |
| Device |
absorb gt1 bvs |
1 |
2017 |
| Device |
absorbâ„¢ bvs |
1 |
2013 |
| Drug |
abt-335/atorvastatin calcium |
1 |
2006 |
| Drug |
abt-335/rosuvastatin calcium |
1 |
2006 |
| Drug |
abt-335/simvastatin |
1 |
2006 |
| Drug |
ace |
1 |
2014 |
| Drug |
ace-i (lisinopril) |
1 |
2018 |
| Drug |
ace-i (lisinopril)/arb (losartan) |
1 |
2018 |
| Drug |
ace/arb continuation |
1 |
2014 |
| Drug |
ace/arb withdrawal |
1 |
2014 |
| Drug |
acetated ringer`s solution |
1 |
2011 |
| Drug |
acetylcholine |
1 |
2018 |
| Drug |
acetylsalicyclic acid (asa) |
1 |
2006 |
| Drug |
acetylsalicylic acid 75mg tablet |
1 |
2016 |
| Drug |
acp-501 |
1 |
2012 |
| Procedure |
acr-pci |
1 |
2018 |
| Drug |
act-246475 |
1 |
2017 |
| Other |
action plans |
1 |
2009 |
| Radiation |
active comparator: invasive coronary angiography (ica) |
1 |
2013 |
| Behavioral |
active comparator: traditional expressive writing |
1 |
2010 |
| Procedure |
acute normovolemic hemodilution |
1 |
2017 |
| Drug |
adenosine infusion at 200î¼g |
1 |
2015 |
| Drug |
adenosine infusion at 200î¼g/kg/min |
1 |
2015 |
| Other |
adenosine stress dual-source ctp |
1 |
2009 |
| Drug |
adjustment of clopidogrel dose |
1 |
2006 |
| Device |
adrcs processed by the celution system |
1 |
2012 |
| Biological |
adult stem cells |
1 |
2009 |
| Other |
advanced cardiac imaging |
1 |
2010 |
| Device |
advanced monitoring |
1 |
2008 |
| Biological |
advegfxc1 |
1 |
2019 |
| Behavioral |
advice in exercise training ( |
1 |
2011 |
| Behavioral |
advice in exercise training (/ex) |
1 |
2011 |
| Behavioral |
advice on what food to choose |
1 |
2016 |
| Behavioral |
advice on what food to choose/eat |
1 |
2016 |
| Other |
aerobic |
1 |
2013 |
| Other |
aerobic exercises |
1 |
2019 |
| Behavioral |
aerobic interval training |
1 |
2010 |
| Other |
aerobic training (aero) |
1 |
2017 |
| Other |
aerobic/strength training |
1 |
2013 |
| Dietary Supplement |
aged garlic extract (age) |
1 |
2019 |
| Dietary Supplement |
aged garlic extract/coenzyme q10 |
1 |
2009 |
| Device |
agent paclitaxel-coated balloon |
1 |
2014 |
| Drug |
aggressive lipid therapy |
1 |
2012 |
| Procedure |
aggressive strategy |
1 |
2008 |
| Drug |
ai-700 |
1 |
2008 |
| Other |
ait group |
1 |
2016 |
| Drug |
aleglitazar |
1 |
2012 |
| Drug |
alirocumab 75 mg |
1 |
2018 |
| Drug |
alirocumab 75 mg/ml [praluent]/ rosuvastatin 10mg/daily |
1 |
2018 |
| Drug |
alirocumab sar236553 |
1 |
2016 |
| Drug |
allopurinol |
1 |
2013 |
| Drug |
alpha-lipoic acid |
1 |
2013 |
| Drug |
alt-2074 |
1 |
2007 |
| Other |
alternate day fasting |
1 |
2009 |
| Other |
altitude simulation |
1 |
2014 |
| Other |
ambient air |
1 |
2017 |
| Behavioral |
ambio health remote monitoring |
1 |
2017 |
| Procedure |
ambulation orderly |
1 |
2015 |
| Drug |
amiloride |
1 |
2010 |
| Dietary Supplement |
amino acids |
1 |
2015 |
| Device |
amm aptitude bioresorbable drug-eluting coronary scaffold |
1 |
2015 |
| Device |
amm magnitude bioresorbable drug-eluting coronary scaffold |
1 |
2016 |
| Device |
amplatzer vascular plug 4 |
1 |
2018 |
| Drug |
anacetrapib |
1 |
2008 |
| Drug |
anagliptin |
1 |
2014 |
| Drug |
anakinra |
1 |
2012 |
| Procedure |
anchoring technique |
1 |
2017 |
| Drug |
androgel 5 grams |
1 |
2006 |
| Procedure |
anesthesia for coronary artery surgery |
1 |
2005 |
| Drug |
anfibatide |
1 |
2012 |
| Procedure |
angio-guided cabg |
1 |
2018 |
| Procedure |
angio-guided pci |
1 |
2005 |
| Device |
angio-guided pci with ees |
1 |
2012 |
| Device |
angio-guided pci with ees/bes |
1 |
2012 |
| Procedure |
angio-guided surgical revascularization |
1 |
2014 |
| Procedure |
angio-pci |
1 |
2018 |
| Procedure |
angio guided cabg |
1 |
2020 |
| Procedure |
angiographic guided pci |
1 |
2017 |
| Procedure |
angiography-derived ffr |
1 |
2020 |
| Procedure |
angiography-guided cabg |
1 |
2015 |
| Device |
angiography-guided paclitaxel drug-coated balloon angioplasty |
1 |
2020 |
| Device |
angiography-guided pci |
1 |
2018 |
| Device |
angiography-guided pci with bioresorbable vascular scaffold |
1 |
2015 |
| Device |
angiography guidance |
1 |
2020 |
| Device |
angiography guided percutaneous coronary angioplasty with resolute integrity stent insertion |
1 |
2013 |
| Device |
angiography/optical coherence tomography evaluations |
1 |
2017 |
| Device |
angioguard distal protection device |
1 |
2005 |
| Device |
angiolite |
1 |
2017 |
| Device |
angiolite stent |
1 |
2016 |
| Procedure |
angioplasty |
1 |
2019 |
| Device |
angiosculpt scoring balloon catheter |
1 |
2008 |
| Device |
angiosculptâ® scoring balloon catheter |
1 |
2008 |
| Procedure |
antegrade wire escalation strategy |
1 |
2015 |
| Dietary Supplement |
anthocyanins |
1 |
2018 |
| Drug |
anti-ischemic drug therapy |
1 |
2006 |
| Drug |
anticoagulants |
1 |
2016 |
| Drug |
antidepressant medications |
1 |
2015 |
| Device |
antigravity treadmill (alter-g) |
1 |
2015 |
| Drug |
antiplatelet therapy |
1 |
2019 |
| Drug |
antiplatelets |
1 |
2016 |
| Device |
any abiomed impellaâ® device approved for use in high-risk pci |
1 |
2015 |
| Other |
aorta |
1 |
2012 |
| Procedure |
aortic no-touch opcabg |
1 |
2017 |
| Procedure |
aortoradial graft (free ra) |
1 |
2013 |
| Device |
app support programme (asp) group |
1 |
2019 |
| Drug |
aprotinin |
1 |
2005 |
| Procedure |
aprotinine |
1 |
2005 |
| Drug |
arb (losartan) |
1 |
2018 |
| Drug |
arb continuation |
1 |
2014 |
| Drug |
arb withdrawal |
1 |
2014 |
| Drug |
argatroban |
1 |
2007 |
| Device |
art18z bioresorbable stent |
1 |
2013 |
| Other |
arterial doppler for screening asymptomatic |
1 |
2007 |
| Other |
arterial doppler for screening asymptomatic/significant extracoronary arterial stenoses in all arterial beds |
1 |
2007 |
| Device |
artimes pro low profile dilatation catheter |
1 |
2017 |
| Drug |
aspirin / clopidogrel |
1 |
2017 |
| Drug |
aspirin / placebo |
1 |
2009 |
| Drug |
aspirin / plavix (clopidogrel bisulfate) |
1 |
2009 |
| Drug |
aspirin / pregrel (clopidogrel resinate) |
1 |
2009 |
| Drug |
aspirin / ticagrelor |
1 |
2015 |
| Drug |
aspirin 100 mg |
1 |
2015 |
| Drug |
aspirin continuation |
1 |
2014 |
| Drug |
aspirin discontinuation |
1 |
2014 |
| Drug |
aspirin enteric-coated tablets |
1 |
2012 |
| Drug |
aspirin loading dose |
1 |
2014 |
| Drug |
aspirin maintenance dose |
1 |
2014 |
| Drug |
aspirin tablets |
1 |
2007 |
| Drug |
aspirin, betaloc, atorvastatin, rosuvastatin, clopidogrel, ticagrelor |
1 |
2017 |
| Drug |
aspirin, prasugrel |
1 |
2009 |
| Drug |
aspirin/clopidogrel |
1 |
2009 |
| Drug |
aspirin/clopidogrel / prasugrel |
1 |
2009 |
| Drug |
aspirin/p2y12 antagonist |
1 |
2014 |
| Drug |
aspirin/thienopyridine |
1 |
2011 |
| Drug |
atenolol |
1 |
2005 |
| Drug |
atenolol/hctz/trandolapril |
1 |
2005 |
| Drug |
atorvastatin-esomeprazole |
1 |
2009 |
| Drug |
atorvastatin-omeprazole |
1 |
2009 |
| Drug |
atorvastatin-pantoprazole |
1 |
2009 |
| Drug |
atorvastatin-ranitidine |
1 |
2009 |
| Drug |
atorvastatin (drug) |
1 |
2006 |
| Drug |
atorvastatin 10mg versus 40mg. |
1 |
2010 |
| Drug |
atorvastatin 20 mg / pioglitazone 30 mg |
1 |
2011 |
| Drug |
atorvastatin 20mg |
1 |
2011 |
| Drug |
atorvastatin 40 mg |
1 |
2007 |
| placebo |
atorvastatin vs placebo |
1 |
2009 |
| Drug |
atorvastatin, high vs low dose |
1 |
2009 |
| Drug |
atorvastatin, lipitor |
1 |
2006 |
| Drug |
atorvastatin,pravastatin |
1 |
2006 |
| Drug |
atorvastatin; fenofibrate; niacin |
1 |
2007 |
| Behavioral |
attention comparison |
1 |
2012 |
| Behavioral |
attention control |
1 |
2019 |
| Procedure |
audience response system |
1 |
2014 |
| Biological |
auto-cd34 |
1 |
2012 |
| Biological |
auto-cd34/ cells |
1 |
2012 |
| Procedure |
autologous bone marrow derived stem cells myocardial transplantation |
1 |
2008 |
| Drug |
autologous cd34 |
1 |
2018 |
| Drug |
autologous cd34/ cells |
1 |
2018 |
| Other |
autologous stem cells |
1 |
2008 |
| Device |
aviâ® arsenic trioxide drug eluting stent |
1 |
2014 |
| Device |
aviâ® arsenic trioxide drug eluting stent delivery system |
1 |
2014 |
| Other |
ayurveda |
1 |
2014 |
| Drug |
azd5718 |
1 |
2017 |
| Drug |
azd5718 film-coated tablet, reference treatment |
1 |
2019 |
| Drug |
azd5718 ir tablet |
1 |
2016 |
| Drug |
azd5718 tablet, formulation a |
1 |
2019 |
| Drug |
azd5718 tablet, formulation b |
1 |
2019 |
| Drug |
azd5718 tablet, formulation c |
1 |
2019 |
| Drug |
azd5718 tablet, formulation d |
1 |
2019 |
| Drug |
azd6140 |
1 |
2008 |
| Drug |
azithromycin capsule |
1 |
2018 |
| Drug |
b-blockers |
1 |
2018 |
| Drug |
b6 |
1 |
2008 |
| Dietary Supplement |
b6 vitamin |
1 |
2018 |
| Other |
background care |
1 |
2012 |
| Device |
balloon |
1 |
2017 |
| Procedure |
balloon-stent kissing technique |
1 |
2018 |
| Device |
balloon angioplasty |
1 |
2006 |
| Device |
bare metal bx velocityâ„¢ |
1 |
2005 |
| Device |
bare metal coronary stent |
1 |
2006 |
| Device |
bd-des (biodegradable polymer drug-eluting stent) |
1 |
2014 |
| Other |
bed rotation group |
1 |
2015 |
| Behavioral |
behavioral |
1 |
2006 |
| Behavioral |
behavioral counseling |
1 |
2006 |
| Behavioral |
behavioral counseling/peer support |
1 |
2006 |
| Behavioral |
behavioral intervention |
1 |
2012 |
| Behavioral |
behavioral interventional program |
1 |
2009 |
| Behavioral |
behavioral modification |
1 |
2018 |
| Behavioral |
behavioral program a |
1 |
2008 |
| Behavioral |
behavioral program b |
1 |
2008 |
| Device |
bes |
1 |
2012 |
| Other |
best available therapy |
1 |
2013 |
| Drug |
beta-carotene |
1 |
1999 |
| Drug |
beta blocker |
1 |
2018 |
| Drug |
betablocker, diuretics, acei, arb, |
1 |
2007 |
| Drug |
bezafibrate |
1 |
2016 |
| placebo |
bfgf:placebo plasmid |
1 |
2008 |
| Drug |
bfpet |
1 |
2008 |
| Drug |
biap |
1 |
2009 |
| Device |
bioabsorbable everolimus eluting coronary stent |
1 |
2009 |
| Device |
biodegradable-polymer stent |
1 |
2016 |
| Device |
biodegradable polymer-des |
1 |
2010 |
| Device |
biodegradable polymer limus-eluting stents |
1 |
2010 |
| Device |
biodegradable polymer rapamycin-eluting stent |
1 |
2008 |
| Device |
biofreedom |
1 |
2015 |
| Device |
biofreedom with 1 month dapt |
1 |
2015 |
| Device |
biofreedomâ„¢ cocr biolimus a9â„¢ stent |
1 |
2017 |
| Device |
biofreedomâ„¢ ss biolimus a9â„¢ stent |
1 |
2017 |
| Device |
biolimus-eluting stent |
1 |
2011 |
| Device |
biolimus a9-eluting stent |
1 |
2010 |
| Device |
biolimus eluting bioresorbable polymer stent |
1 |
2014 |
| Device |
biolimus eluting stent |
1 |
2017 |
| Device |
biolinx polymer-based zotarolimus-eluting stents |
1 |
2017 |
| Other |
biological measurements |
1 |
2011 |
| Device |
biomatrix |
1 |
2015 |
| Drug |
biomatrix drug eluting stent |
1 |
2014 |
| Device |
biomatrix flex stent |
1 |
2012 |
| Device |
biomatrix neoflex coronary stent |
1 |
2014 |
| Device |
biomatrix stent |
1 |
2012 |
| Device |
biomatrix/ultimaster with 6 to 12 months dapt |
1 |
2015 |
| Procedure |
biopsy |
1 |
2013 |
| Device |
bioresorbable vascular scaffolds (bvs) |
1 |
2017 |
| Device |
biosensors biofreedom ba9 drug coated coronary stent |
1 |
2017 |
| Drug |
bisoprolol |
1 |
2006 |
| Drug |
bisoprolol fumarate 2.5 mg oral tablet |
1 |
2016 |
| Drug |
bivalirudin use during epci |
1 |
2019 |
| Procedure |
blood sampling - genotyping |
1 |
2007 |
| Procedure |
blood sampling - platelet aggregation |
1 |
2007 |
| Other |
blood sampling from the coronary sinus |
1 |
2012 |
| Other |
blood sampling from the coronary sinus/aorta |
1 |
2012 |
| Diagnostic Test |
blood test |
1 |
2019 |
| Combination Product |
bmmscs |
1 |
2017 |
| Device |
bodymedia |
1 |
2011 |
| Drug |
bone marrow derived autologous cd133 |
1 |
2016 |
| Drug |
bone marrow derived autologous cd133/ selected cell product |
1 |
2016 |
| Other |
bone marrow mononuclear cells |
1 |
2011 |
| Device |
boston scientific fully absorbable scaffold |
1 |
2015 |
| Procedure |
brachial artery reactivity study |
1 |
2003 |
| Dietary Supplement |
brazilian cardioprotective diet |
1 |
2018 |
| Dietary Supplement |
brazilian cardioprotective diet/30g/day of mixed nuts |
1 |
2018 |
| Device |
breathhold spect-mpi |
1 |
2015 |
| Device |
bridgepoint medical system (crossboss catheter, stingray catheter, entera guidewire) |
1 |
2008 |
| Device |
bs-des (biostable polymer drug-eluting stent) |
1 |
2014 |
| Device |
buma |
1 |
2013 |
| Device |
buma stent |
1 |
2012 |
| Device |
buma supreme des |
1 |
2017 |
| Device |
bumaâ„¢ |
1 |
2016 |
| Drug |
bupivacaine group |
1 |
2018 |
| Drug |
bupivacaine hydrochloride |
1 |
2017 |
| Behavioral |
burst physical activity |
1 |
2017 |
| Device |
bvs |
1 |
2016 |
| Device |
bvs absorb scaffold |
1 |
2016 |
| Device |
bvs/omt |
1 |
2016 |
| Device |
bx cypher stent |
1 |
2005 |
| Device |
bx sonic bare metal stent |
1 |
2007 |
| Device |
bx velocity stent containing 45% |
1 |
2005 |
| Device |
bx velocity stent containing 45%/70% of sirolimus dose |
1 |
2005 |
| Device |
c-cathezâ® catheter |
1 |
2017 |
| Procedure |
cabg / mitral valve annuloplasty |
1 |
2006 |
| Device |
cabg/savr |
1 |
2018 |
| Other |
cacs |
1 |
2013 |
| Other |
cad |
1 |
2018 |
| Behavioral |
cad education |
1 |
2014 |
| Device |
cadscorâ®system |
1 |
2019 |
| Other |
cag-guided strategy |
1 |
2019 |
| Drug |
calcium channel blockers (amlodipine, azelnidipine) |
1 |
2006 |
| Dietary Supplement |
calorie-restricted diet |
1 |
2018 |
| Other |
calorie restriction |
1 |
2009 |
| Procedure |
cardiac computed tomographic angiography (ccta) |
1 |
2011 |
| Device |
cardiac computer tomography |
1 |
2011 |
| Procedure |
cardiac ct |
1 |
2013 |
| Diagnostic Test |
cardiac ct angiogram |
1 |
2018 |
| Device |
cardiac ct scan |
1 |
2014 |
| Behavioral |
cardiac education class |
1 |
2005 |
| Other |
cardiac educational program |
1 |
2019 |
| Device |
cardiac gsi |
1 |
2013 |
| Diagnostic Test |
cardiac magnetic resonance |
1 |
2017 |
| Other |
cardiac magnetic resonance (cmr) imaging techniques |
1 |
2016 |
| Drug |
cardiac mri taken using contrast agent, dotaremâ® (gd-dota) |
1 |
2017 |
| Drug |
cardiac mri with contrast agent, gadovist |
1 |
2017 |
| Drug |
cardiac pet scan w |
1 |
2013 |
| Drug |
cardiac pet scan w/18f-fluorodeoxyglucose/rubidium-82 |
1 |
2013 |
| Other |
cardiac rehabilitation clinic |
1 |
2014 |
| Behavioral |
cardiac rehabilitation peer mentorship |
1 |
2014 |
| Device |
cardiac shock wave therapy |
1 |
2017 |
| Device |
cardiac shock wave therapy(cswt) |
1 |
2012 |
| Procedure |
cardiac spect imaging rest |
1 |
2005 |
| Procedure |
cardiac spect imaging rest/stress |
1 |
2005 |
| Device |
cardiac stabilizer instead of cardiopulmonary bypass |
1 |
2005 |
| Procedure |
cardiac surgery |
1 |
2009 |
| Procedure |
cardiac surgery scheduled in the afternoon |
1 |
2016 |
| Procedure |
cardiac surgery scheduled in the morning |
1 |
2016 |
| Behavioral |
cardiofit |
1 |
2005 |
| Device |
cardiogoniometry (cgm) |
1 |
2016 |
| Drug |
cardiopet |
1 |
2006 |
| Drug |
cardiopetâ„¢ |
1 |
2013 |
| Diagnostic Test |
cardiopulmonary exercise testing |
1 |
2017 |
| Other |
cardiovascular magnetic resonance imaging |
1 |
2012 |
| Procedure |
cardiovascular measurement |
1 |
2016 |
| Procedure |
cardiovascular rehabilitation program using kinect of xbox |
1 |
2016 |
| Procedure |
cardiovascular rehabilitation program using paper manual |
1 |
2016 |
| Other |
carotid ultrasound |
1 |
2008 |
| Drug |
carvedilol |
1 |
2008 |
| Behavioral |
case managed home program |
1 |
2018 |
| Procedure |
catheterization |
1 |
2009 |
| Device |
catheterization, stent deployment |
1 |
2009 |
| Behavioral |
cbcr |
1 |
2018 |
| Behavioral |
cbt hostility reduction program |
1 |
2006 |
| Procedure |
ccta (coronary computed tomography angiography) |
1 |
2012 |
| Radiation |
ccta ~ breast shields |
1 |
2015 |
| Diagnostic Test |
ccta with selective ffrct |
1 |
2018 |
| Procedure |
cell therapy |
1 |
2012 |
| Genetic |
cell therapy - autologous cd34 positive cells |
1 |
2004 |
| Device |
celt acd |
1 |
2012 |
| Device |
celution system |
1 |
2014 |
| Behavioral |
center-based cardiac rehabilitation |
1 |
2014 |
| Procedure |
centrifugation |
1 |
2011 |
| Device |
cep magna mitral pericardial bioprostheses |
1 |
2009 |
| Other |
cgms |
1 |
2013 |
| Drug |
cgt003 (e2f duplex decoy) |
1 |
2002 |
| Behavioral |
change |
1 |
2014 |
| Other |
change in the timing of components of usual care |
1 |
2018 |
| Behavioral |
change/ |
1 |
2014 |
| Drug |
chewable aspirin |
1 |
2008 |
| Drug |
chixiangshen tongxin granules |
1 |
2011 |
| Other |
choice of hospital |
1 |
2018 |
| Other |
choice of hospital/home-based cr / movn application |
1 |
2018 |
| Other |
choice of hospital/home-based cr / movn application / nudge |
1 |
2018 |
| Behavioral |
cholesterol lowering diet |
1 |
2008 |
| Behavioral |
choral singing |
1 |
2017 |
| Procedure |
chronic total occlusion percutaneous coronary intervention |
1 |
2016 |
| Procedure |
chronic total occlusion revascularization |
1 |
2019 |
| Device |
chrono carbostent carbofilmâ„¢ coated coronary stent |
1 |
2009 |
| Other |
cigarettes |
1 |
2015 |
| Drug |
cilostazol 100mg |
1 |
2013 |
| Drug |
cilostazol 100mg bid |
1 |
2009 |
| Drug |
cilostazol 100mg bid/clopidogrel 150-mg daily |
1 |
2009 |
| Device |
cilostazol eluting stent system (ces-1) |
1 |
2017 |
| Drug |
cilostazol in addition to aspirin |
1 |
2006 |
| Drug |
cilostazol in addition to aspirin/clopidogrel |
1 |
2006 |
| Device |
cilotax stent |
1 |
2012 |
| Drug |
cipher prescription 1 |
1 |
2009 |
| Drug |
cipher prescription 2 |
1 |
2009 |
| Drug |
clarithromycin |
1 |
2005 |
| Biological |
clbs16 |
1 |
2018 |
| Other |
clearsight measurement |
1 |
2016 |
| Behavioral |
climb intervention |
1 |
2018 |
| Procedure |
clinical follow-up |
1 |
2010 |
| Drug |
clopidogrel (over encapsulated) capsule |
1 |
2007 |
| Drug |
clopidogrel / aspirin |
1 |
2013 |
| Drug |
clopidogrel / aspirin/prasugrel / aspirin |
1 |
2010 |
| Drug |
clopidogrel 150-mg daily |
1 |
2009 |
| Drug |
clopidogrel 150mg |
1 |
2013 |
| Drug |
clopidogrel 600 mg |
1 |
2014 |
| Drug |
clopidogrel 75 mg |
1 |
2015 |
| Drug |
clopidogrel 75 mg daily |
1 |
2005 |
| Drug |
clopidogrel active metabolite |
1 |
2018 |
| Drug |
clopidogrel after everolimus-eluting stent implantation |
1 |
2007 |
| Drug |
clopidogrel after paclitaxel-eluting stent implantation |
1 |
2007 |
| Drug |
clopidogrel after zotarolimus-eluting stent implantation |
1 |
2007 |
| Drug |
clopidogrel bisulfate |
1 |
2012 |
| Drug |
clopidogrel bisulfate / aspirin |
1 |
2012 |
| Drug |
clopidogrel mono-therapy |
1 |
2019 |
| Drug |
clopidogrel monotherapy |
1 |
2017 |
| Drug |
clopidogrel napadisilate |
1 |
2012 |
| Drug |
clopidogrel napadisilate / aspirin |
1 |
2012 |
| placebo |
clopidogrel placebo |
1 |
2006 |
| Drug |
clopidogrel treatment |
1 |
2010 |
| Drug |
clopidogrel treatment after bare metal stent implantation |
1 |
2007 |
| Drug |
clopidogrel/aspirin |
1 |
2011 |
| Drug |
clopidogrel/aspirin, prasugrel/aspirin |
1 |
2009 |
| Drug |
clopidogrel/rifampicin |
1 |
2008 |
| Procedure |
closure device |
1 |
2005 |
| Diagnostic Test |
cmr |
1 |
2017 |
| Device |
cmr imaging |
1 |
2016 |
| Drug |
cmx-2043 |
1 |
2009 |
| Dietary Supplement |
cocoa flavanols |
1 |
2007 |
| Behavioral |
cognitive behavioral therapy (cbt) |
1 |
2007 |
| Other |
cognitive testing |
1 |
2016 |
| Drug |
colchicine 0.25 mg |
1 |
2017 |
| Drug |
colchicine 0.5 mg |
1 |
2017 |
| placebo |
colchicine placebo |
1 |
2015 |
| placebo |
colchicine vs placebo |
1 |
2015 |
| Other |
cold |
1 |
2016 |
| Drug |
cold blood cardioplegia |
1 |
2012 |
| Drug |
colesevelam |
1 |
2008 |
| Behavioral |
collaborative care |
1 |
2012 |
| Behavioral |
collaborative care chd |
1 |
2014 |
| Behavioral |
collaborative care treatment |
1 |
2009 |
| Drug |
collastat |
1 |
2020 |
| Drug |
combination therapy with lipitor [atorvastatin] |
1 |
2010 |
| Drug |
combination therapy with lipitor [atorvastatin]/zetia [ezetimibe] |
1 |
2010 |
| Other |
combined - pad |
1 |
2018 |
| Other |
combined - pad/cad |
1 |
2018 |
| Procedure |
combined cabg |
1 |
2011 |
| Procedure |
combined cabg/pci |
1 |
2011 |
| Procedure |
combined exercise |
1 |
2013 |
| Drug |
combined therapy with enoximone |
1 |
2006 |
| Drug |
combined therapy with enoximone/esmolol |
1 |
2006 |
| Device |
combo |
1 |
2017 |
| Device |
combomap xt guidewire |
1 |
2014 |
| Other |
comedy |
1 |
2016 |
| Behavioral |
communicational program “trust” |
1 |
2017 |
| Drug |
comparator: atorvastatin |
1 |
2007 |
| placebo |
comparator: placebo |
1 |
2008 |
| Other |
comprehensive assessment |
1 |
2019 |
| Other |
comprehensive phase one rehabilitation |
1 |
2014 |
| Other |
comprehensive therapy program for risk factor modification |
1 |
2008 |
| Radiation |
computed coronary angiography |
1 |
2012 |
| Procedure |
computed tomographic angiography |
1 |
2007 |
| Device |
computed tomographic coronary angiography |
1 |
2015 |
| Procedure |
computed tomography |
1 |
2014 |
| Procedure |
computed tomography angiography (cardiac ct) |
1 |
2015 |
| Device |
computer-assisted history |
1 |
2007 |
| Other |
computer-assisted history taking |
1 |
2007 |
| Procedure |
computer tomography angiography |
1 |
2010 |
| Behavioral |
computerized reminders hypertension management |
1 |
2005 |
| Behavioral |
computerized reminders medications monitoring |
1 |
2005 |
| Behavioral |
computerized reminders osteoporosis screening |
1 |
2005 |
| Behavioral |
computerized reminders osteoporosis screening/mgt |
1 |
2005 |
| Behavioral |
computerized test results management application |
1 |
2005 |
| Procedure |
concomitant mapping |
1 |
2017 |
| Procedure |
concomitant mapping/radiofrequency ablation |
1 |
2017 |
| Other |
connected cvr programme |
1 |
2017 |
| Device |
conor medsystems costarâ„¢ stent (10 âµg paclitaxel) |
1 |
2009 |
| Device |
conor medsystems costarâ„¢ stent (30 âµg paclitaxel) |
1 |
2009 |
| Other |
conservative arm |
1 |
2007 |
| Procedure |
conservative strategy |
1 |
2008 |
| Other |
conservative treatment arm |
1 |
2016 |
| Behavioral |
consult |
1 |
2012 |
| Behavioral |
consult/behavioral intervention |
1 |
2012 |
| Behavioral |
consultation with endocrinologist |
1 |
2005 |
| Other |
consume 2 eggs with spinach per day |
1 |
2020 |
| Behavioral |
consumption of dietary portfolio |
1 |
2007 |
| Behavioral |
cont |
1 |
2016 |
| Other |
continuous endurance training |
1 |
2014 |
| Other |
continuous exercise training |
1 |
2014 |
| Device |
continuous positive airway pressure |
1 |
2014 |
| Device |
continuous positive airway pressure ventilator |
1 |
2014 |
| Other |
continuous versus interval training |
1 |
2008 |
| Procedure |
continuous, mechanical ventilatory support |
1 |
2012 |
| Other |
contrast enhanced mri with gadofosveset |
1 |
2009 |
| Other |
control (plasma) |
1 |
2006 |
| Behavioral |
control group :conventional exercise rehabilitation |
1 |
2019 |
| Device |
control group training without guided exercise system at home |
1 |
2012 |
| Device |
control stent |
1 |
2006 |
| Procedure |
control technique |
1 |
2018 |
| Device |
conventional |
1 |
2020 |
| Procedure |
conventional angioplasty |
1 |
2013 |
| Other |
conventional antidiabetic treatment |
1 |
2006 |
| Procedure |
conventional coronary artery bypass surgery |
1 |
2014 |
| Drug |
conventional coronary heart disease medicine |
1 |
2018 |
| Other |
conventional cvr programme |
1 |
2017 |
| Procedure |
conventional extracorporeal circulation |
1 |
2017 |
| Drug |
conventional medical treatment |
1 |
2013 |
| Drug |
conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)/traditional chinese medicines (tcms) granules |
1 |
2012 |
| Device |
conventional monitoring |
1 |
2008 |
| Procedure |
conventional open svg harvesting |
1 |
2011 |
| Procedure |
conventional strategy |
1 |
2015 |
| Drug |
conventional strategy aspirin |
1 |
2015 |
| Procedure |
conventional technique |
1 |
2012 |
| Other |
conventional therapy |
1 |
2019 |
| Device |
conventional treadmill |
1 |
2015 |
| Device |
conventional treadmill/regadenoson |
1 |
2015 |
| Procedure |
conventional vein harvesting |
1 |
2017 |
| Procedure |
conventional vein harvesting technique |
1 |
2018 |
| Device |
core size xience prime |
1 |
2009 |
| Device |
coroflex blue (bms) followed by sequent please (deb) |
1 |
2010 |
| Device |
coroflex please (des) |
1 |
2010 |
| Device |
coroflexâ® isar drug-eluting stent |
1 |
2016 |
| Device |
coroflextm please |
1 |
2009 |
| Procedure |
coronary angiography (cag) |
1 |
2007 |
| Procedure |
coronary angiography //- percutaneous coronary intervention |
1 |
2019 |
| Procedure |
coronary artery bypass |
1 |
2005 |
| Procedure |
coronary artery bypass - off-pump |
1 |
2002 |
| Procedure |
coronary artery bypass - on-pump |
1 |
2002 |
| Procedure |
coronary artery bypass graft |
1 |
2007 |
| Procedure |
coronary artery bypass graft (cabg) surgery |
1 |
2005 |
| Procedure |
coronary artery bypass graft operation |
1 |
2011 |
| Procedure |
coronary artery bypass grafting (cabg) |
1 |
2018 |
| Procedure |
coronary artery bypass grafting via midline sternotomy |
1 |
2008 |
| Procedure |
coronary artery bypass surgery |
1 |
2015 |
| Procedure |
coronary artery bypass vein grafts |
1 |
2017 |
| Other |
coronary artery calcium (cac) scan |
1 |
2009 |
| Other |
coronary artery disease |
1 |
2013 |
| Behavioral |
coronary artery disease decision aid |
1 |
2008 |
| Device |
coronary artery drug eluting stent placement |
1 |
2005 |
| Device |
coronary artery stent placement |
1 |
2005 |
| Device |
coronary artery stenting: absorb bvs |
1 |
2014 |
| Device |
coronary balloons |
1 |
2017 |
| Procedure |
coronary bypass surgery without cardiopulmonary bypass |
1 |
2005 |
| Procedure |
coronary catheterisation |
1 |
2007 |
| Diagnostic Test |
coronary computed tomography |
1 |
2019 |
| Procedure |
coronary ct angiography on somatom force |
1 |
2014 |
| Other |
coronary cta imaging |
1 |
2015 |
| Device |
coronary drug eluting stents for pci |
1 |
2005 |
| Device |
coronary intervention (genous stent) |
1 |
2010 |
| Device |
coronary intervention using ivus-vh |
1 |
2010 |
| Device |
coronary intervention using ivus-vh/fdg pet-mdct |
1 |
2010 |
| Procedure |
coronary lithoplasty |
1 |
2019 |
| Device |
coronary optical coherence tomography |
1 |
2019 |
| Procedure |
coronary pci guided by ivus |
1 |
2014 |
| Procedure |
coronary revascularization |
1 |
2009 |
| Device |
coronary stent - tsunami |
1 |
2012 |
| Device |
coronary stent (genous, orbusneich) with immobilised anti-cd34 antibody to capture circulating endothelial progenitor cells |
1 |
2007 |
| Device |
coronary stent cypher |
1 |
2010 |
| Device |
coronary stent placement |
1 |
2006 |
| Device |
coronary stent system |
1 |
2012 |
| Device |
coronary stent xience |
1 |
2010 |
| Device |
coronary wires. stents |
1 |
2017 |
| Device |
coronary wires. stents/coronary balloons |
1 |
2017 |
| Device |
corpath 200 |
1 |
2010 |
| Device |
corpath robotic-assisted pci |
1 |
2011 |
| Device |
corrie digital health platform |
1 |
2018 |
| Behavioral |
counseling from diabetes educator |
1 |
2005 |
| Behavioral |
counseling from dietician |
1 |
2005 |
| Other |
cpr anytime education |
1 |
2007 |
| Dietary Supplement |
cranberry juice |
1 |
2007 |
| Device |
cre8 sirolimus-eluting stent |
1 |
2015 |
| Dietary Supplement |
creatine |
1 |
2007 |
| Dietary Supplement |
creatine, d-ribose, b1 vitamin, |
1 |
2018 |
| Dietary Supplement |
creatine, d-ribose, b1 vitamin,/b6 vitamin |
1 |
2018 |
| Procedure |
crossboss catheter |
1 |
2015 |
| Device |
crossing of coronary artery cto |
1 |
2015 |
| Procedure |
crush technique |
1 |
2008 |
| Combination Product |
cswt/bmmscs |
1 |
2017 |
| Device |
cswt/sham operation |
1 |
2017 |
| Diagnostic Test |
ct-ffr |
1 |
2019 |
| Other |
ct-mpi |
1 |
2015 |
| Other |
ct-mpi/spect-mpi |
1 |
2015 |
| Procedure |
ct angiography with high concentration contrast agent |
1 |
2015 |
| Procedure |
ct angiography with low concentration contrast agent (270) |
1 |
2015 |
| Procedure |
ct angiography with low concentration contrast agent (320) |
1 |
2015 |
| Diagnostic Test |
ct as part of standard care, not a comparator |
1 |
2018 |
| Other |
ct calcium score |
1 |
2012 |
| Radiation |
ct coronary angiography (ctca) |
1 |
2019 |
| Procedure |
ct guided pci |
1 |
2010 |
| Procedure |
ct/mr |
1 |
2009 |
| Diagnostic Test |
cta |
1 |
2019 |
| Diagnostic Test |
cta/ffrct |
1 |
2019 |
| Diagnostic Test |
ctca |
1 |
2018 |
| Radiation |
ctca imaging |
1 |
2018 |
| Device |
cto treatment device |
1 |
2011 |
| Other |
current practice |
1 |
2018 |
| Device |
currently common drug-eluting stent (des) |
1 |
2016 |
| Drug |
custodiol htk |
1 |
2012 |
| Device |
cutting |
1 |
2015 |
| Device |
cutting balloon |
1 |
2013 |
| Device |
cutting balloon angioplasty |
1 |
2017 |
| Device |
cutting/scoring balloon |
1 |
2015 |
| Genetic |
cyp2c19 test |
1 |
2018 |
| Device |
cypher-stent (implantation of a sirolimus-eluting stent) |
1 |
2008 |
| Device |
cypher nxt ses on bx sonic otw stent delivery system (sds) |
1 |
2005 |
| Device |
cypher select/secss |
1 |
2010 |
| Device |
cyphertm sirolimus-eluting coronary stent |
1 |
2005 |
| Other |
cytology specimen collection procedure |
1 |
2014 |
| Device |
cytosorb device |
1 |
2014 |
| Diagnostic Test |
czt spect acquisition |
1 |
2018 |
| Device |
czt spect camera |
1 |
2016 |
| Drug |
daily |
1 |
2018 |
| Drug |
dapagliflozin 10mg tab |
1 |
2017 |
| Drug |
dapt |
1 |
2017 |
| Drug |
dapt (aspirin and |
1 |
2019 |
| Drug |
dapt (aspirin and/or p2y12 receptor inhibitor) |
1 |
2019 |
| Drug |
darusentan 100 mg |
1 |
2008 |
| Drug |
day |
1 |
2012 |
| Other |
day light |
1 |
2015 |
| Dietary Supplement |
day of mixed nuts |
1 |
2018 |
| Drug |
day) |
1 |
2005 |
| Device |
deblue stent vs. cypher stent |
1 |
2007 |
| Device |
deblue vs cypher vs bms |
1 |
2007 |
| Other |
decision-making tool for coronary artery disease treatment |
1 |
2014 |
| Behavioral |
decision counseling program (dcp) |
1 |
2008 |
| Other |
deep breathing exercises |
1 |
2016 |
| Other |
deferral of admission for stress test |
1 |
2017 |
| Drug |
delayed continuous use of bivalirudin |
1 |
2019 |
| Procedure |
delayed rotational atherectomy (ra) |
1 |
2012 |
| Procedure |
delayed treatment |
1 |
2010 |
| Behavioral |
delirium assessment |
1 |
2014 |
| Device |
delivery of precise levels of carbon dioxide with the ra-mrâ„¢ virtual sequential gas delivery system. |
1 |
2014 |
| Device |
delivery of rubidium radioisotope (rb-82) using the automated pump |
1 |
2014 |
| Device |
delivery of rubidium radioisotope (rb-82) using the automated pump/elution system |
1 |
2014 |
| Device |
des “calypso” |
1 |
2016 |
| Device |
des “xience prime” |
1 |
2016 |
| Procedure |
des implantation |
1 |
2014 |
| Drug |
desflurane |
1 |
2019 |
| Device |
desolve |
1 |
2016 |
| Device |
desolve cx drug eluting coronary scaffold system |
1 |
2019 |
| Device |
desolve novolimus eluting bioresorbable coronary scaffold |
1 |
2014 |
| Device |
desolve novolimus eluting bioresorbable coronary scaffold system |
1 |
2014 |
| Device |
desyne bd novolimus stent system |
1 |
2008 |
| Device |
desyne novolimus stent system |
1 |
2008 |
| Device |
device implantation during coronary angioplasty |
1 |
2018 |
| Combination Product |
device: medtronic resolute onyx zotarolimus-eluting coronary stent system treatment followed by one-month dapt |
1 |
2018 |
| Device |
device: paclitaxel-coated ptca balloon catheter |
1 |
2019 |
| Drug |
dexmedetomidine, ketamine, magnesium sulfate |
1 |
2019 |
| Other |
diagnostic accuracy |
1 |
2014 |
| Diagnostic Test |
diagnostic coronary angiography with non-obstructive cad |
1 |
2018 |
| Other |
diagnostic test |
1 |
2013 |
| Other |
diagnostic test - cardiac magnetic resonance imaging |
1 |
2015 |
| Other |
diagnostic test - coronary angiography |
1 |
2015 |
| Device |
diamondback 360 orbital atherectomy system |
1 |
2010 |
| Behavioral |
diet, reducing |
1 |
1999 |
| Behavioral |
diet, vegetarianism |
1 |
1999 |
| Other |
dietary |
1 |
2019 |
| Other |
dietary counseling |
1 |
2018 |
| Other |
dietary intervention |
1 |
2008 |
| Behavioral |
dietary supplements |
1 |
1999 |
| Behavioral |
dietary therapy |
1 |
2005 |
| Other |
dietary/physiotherapy |
1 |
2019 |
| Dietary Supplement |
different amount of phytosterols are added into diets |
1 |
2009 |
| Device |
diffuse optical tomography |
1 |
2017 |
| Behavioral |
digital technology |
1 |
2019 |
| Other |
dipi |
1 |
2014 |
| Drug |
diprivan (propofol), astra-zeneca |
1 |
2007 |
| Behavioral |
direct-to-patient tailored cardiovascular risk message system |
1 |
2011 |
| Procedure |
direct compression |
1 |
2005 |
| Other |
direct injection of adrcs into the left ventricle |
1 |
2007 |
| placebo |
direct injection of placebo into the left ventricle |
1 |
2007 |
| Drug |
discontinue dapt |
1 |
2012 |
| Behavioral |
disease-related expressive writing |
1 |
2010 |
| Procedure |
distal radial artery access in coronary angiography |
1 |
2019 |
| Procedure |
distal radial artery access in coronary angiography/angioplasty |
1 |
2019 |
| Procedure |
dk crush |
1 |
2018 |
| Device |
dm |
1 |
2010 |
| Drug |
docosahexanoic acid (dha) |
1 |
2006 |
| Other |
documentary |
1 |
2016 |
| Other |
double-low scanning |
1 |
2018 |
| Drug |
double dose polycap |
1 |
2011 |
| Drug |
doxycycline capsule |
1 |
2018 |
| Behavioral |
dr. dean ornish program for reversing heart disease |
1 |
2013 |
| Device |
drift assessment of optowire deux ffr wire (1) |
1 |
2019 |
| Device |
drift assessment of optowire deux ffr wire (2) |
1 |
2019 |
| Device |
driver cobalt alloy coronary stent |
1 |
2009 |
| Device |
drug-eluting stent (des) - slow |
1 |
2017 |
| Device |
drug-eluting stent (des) - standard(std) |
1 |
2017 |
| Device |
drug-eluting stent/balloon angioplasty |
1 |
2006 |
| Device |
drug eluting-stent |
1 |
2005 |
| Device |
drug eluting balloon / bare metal stent |
1 |
2012 |
| Device |
drug eluting balloon sequent please |
1 |
2008 |
| Device |
drug eluting stent (zotarolimus-eluting stent) |
1 |
2012 |
| Device |
drug eluting stent treatment |
1 |
2010 |
| Drug |
drug infusion (bq-123) |
1 |
2005 |
| Drug |
dual-antiplatelet therapy |
1 |
2019 |
| Drug |
dual antiplatelet |
1 |
2011 |
| Drug |
dual antiplatelet (dapt) therapy |
1 |
2018 |
| Drug |
dual antipletlet therapy (dapt) |
1 |
2014 |
| Behavioral |
dvd |
1 |
2010 |
| Other |
dynamic physical exercise |
1 |
2009 |
| Device |
dynamx sirolimus-eluting coronary bioadaptor system |
1 |
2018 |
| Other |
dynasdy |
1 |
2015 |
| Other |
e-cigarettes (high nicotine e-liquid) |
1 |
2015 |
| Other |
e-cigarettes (low nicotine e-liquid) |
1 |
2015 |
| Other |
e-cigarettes (nicotine free e-liquid) |
1 |
2015 |
| Drug |
e5555 |
1 |
2006 |
| Drug |
e5555 100 mg |
1 |
2007 |
| Drug |
e5555 200 mg |
1 |
2007 |
| Drug |
e5555 50 mg |
1 |
2007 |
| Behavioral |
early appointment (within 10 days) |
1 |
2012 |
| Other |
early cardiac rehabilitation |
1 |
2018 |
| Device |
early deflation of tr band |
1 |
2017 |
| Other |
early discharge |
1 |
2013 |
| Procedure |
early extubation |
1 |
2018 |
| Procedure |
early mobilisation |
1 |
2018 |
| Procedure |
early mobilisation/physiotherapy |
1 |
2018 |
| Behavioral |
eat |
1 |
2016 |
| Other |
ecg |
1 |
2018 |
| Other |
ecg / heart rate |
1 |
2018 |
| Radiation |
echocardiogram |
1 |
2016 |
| Device |
echoclip |
1 |
2016 |
| Device |
ecp therapy |
1 |
2006 |
| Drug |
edoxaban |
1 |
2018 |
| Drug |
edoxaban 30 mg |
1 |
2015 |
| Drug |
edoxaban 60 mg |
1 |
2015 |
| Drug |
edta |
1 |
2002 |
| placebo |
edta placebo |
1 |
2002 |
| Behavioral |
education program |
1 |
2020 |
| Behavioral |
education/reminder |
1 |
2003 |
| Other |
educational component |
1 |
2016 |
| Behavioral |
educational intervention - text |
1 |
2010 |
| Behavioral |
educational intervention - text only |
1 |
2010 |
| Behavioral |
educational intervention - text/dvd/vhs |
1 |
2010 |
| Behavioral |
educational intervention programme |
1 |
2008 |
| Behavioral |
educational model |
1 |
2016 |
| Behavioral |
educational model / follow up |
1 |
2016 |
| Behavioral |
educational program |
1 |
2011 |
| Behavioral |
educational program/telephone follow up |
1 |
2011 |
| Drug |
ee |
1 |
2008 |
| Device |
eeg monitoring |
1 |
2019 |
| Device |
ees (xience) |
1 |
2010 |
| Other |
egg subsitute with spinach per day |
1 |
2020 |
| Dietary Supplement |
egg substitute |
1 |
2011 |
| Dietary Supplement |
egg supplementation |
1 |
2011 |
| Other |
eggs |
1 |
2019 |
| Combination Product |
ehealth |
1 |
2019 |
| Drug |
eicosapentaenoic acid (omega-3 fatty acid) |
1 |
2005 |
| Device |
elective 2-stent |
1 |
2013 |
| Device |
elective fkb |
1 |
2013 |
| Behavioral |
electronic shared decision making (esdm) tool |
1 |
2019 |
| Device |
elution system |
1 |
2014 |
| Device |
emboli capturing guidewire device |
1 |
2005 |
| Device |
emboli capturing guidewire device/with stent |
1 |
2005 |
| Device |
emergeâ„¢ 1.20 mm ptca dilatation catheter |
1 |
2012 |
| Drug |
empagliflozin |
1 |
2017 |
| Drug |
empagliflozin 25 mg |
1 |
2019 |
| Behavioral |
encompass intervention |
1 |
2017 |
| Other |
encourage early oral food intake |
1 |
2018 |
| Device |
endeavor des |
1 |
2011 |
| Device |
endeavor drug eluting coronary stent |
1 |
2008 |
| Device |
endeavor resolute |
1 |
2009 |
| Device |
endeavor resolute (biolinx-based zotarolimus-eluting stent) |
1 |
2010 |
| Device |
endeavor resolute stent |
1 |
2010 |
| Device |
endeavor zotarolimus-eluting coronary stent |
1 |
2008 |
| Device |
endeavorâ® zotarolimus eluting coronary stent system |
1 |
2009 |
| Device |
endeavortm (zotarolimus-eluting stent) |
1 |
2007 |
| Behavioral |
endorsed evidence summaries |
1 |
2005 |
| Procedure |
endoscopic coronary arterial bypass |
1 |
2019 |
| Device |
endoscopic vein harvest |
1 |
2019 |
| Other |
endothelial function guided therapy |
1 |
2019 |
| Other |
endurance training with constant work load |
1 |
2011 |
| Behavioral |
enhance health lifestyle changes |
1 |
2005 |
| Behavioral |
enhance health lifestyle changes/medication compliance |
1 |
2005 |
| Drug |
enoxaparin (high-dose group) |
1 |
2017 |
| Drug |
enoxaparin (single-dose pci group) |
1 |
2017 |
| Drug |
enoxaparin (staged-dose pci group) |
1 |
2017 |
| Drug |
enoxaparin (standard-dose group) |
1 |
2017 |
| Drug |
enoxaparin i.v. |
1 |
2007 |
| Drug |
enteric-coated aspirin |
1 |
2008 |
| Drug |
epa |
1 |
2017 |
| Drug |
epa/high dose rosuvastatin |
1 |
2017 |
| Procedure |
epidural infusion |
1 |
2011 |
| Drug |
eplerenone |
1 |
2005 |
| Drug |
epoetin alpha |
1 |
2007 |
| Drug |
epoetin beta |
1 |
2006 |
| Drug |
eptifibatide |
1 |
2005 |
| Drug |
er niacin |
1 |
2007 |
| Drug |
er niacin/laropiprant |
1 |
2007 |
| Drug |
ergocalciferol |
1 |
2012 |
| Drug |
esmolol |
1 |
2006 |
| Drug |
estradiol |
1 |
2012 |
| Drug |
estrogens, conjugated |
1 |
1999 |
| Drug |
estrogens, conjugated (usp) |
1 |
2004 |
| Drug |
ethinyl estradiol-levonorgestrel combination |
1 |
2012 |
| Behavioral |
ethnicity (rise) |
1 |
2019 |
| Other |
evaluate video clinic visit prior to face-to-face usual care visit |
1 |
2010 |
| Device |
everolimus-eluting coronary stent |
1 |
2014 |
| Device |
everolimus-eluting stent for long lesion |
1 |
2010 |
| Device |
everolimus-eluting stent with a durable polymer |
1 |
2011 |
| Device |
everolimus eluting bioresorbable polymer stent |
1 |
2014 |
| Device |
everolimus eluting stent (ees) |
1 |
2014 |
| Device |
everolimus eluting stent (xience - ees) |
1 |
2009 |
| Drug |
evidence-based medical care for acute coronary syndrome |
1 |
2008 |
| Behavioral |
evidence summaries endorsed by local opinion leaders |
1 |
2005 |
| Drug |
evolocumab 140 mg |
1 |
2019 |
| Drug |
evolocumab 140 mg/ml [repatha] |
1 |
2019 |
| Device |
evolution stent system |
1 |
2010 |
| Behavioral |
ex) |
1 |
2011 |
| Device |
excel |
1 |
2013 |
| Device |
excel stent |
1 |
2012 |
| Device |
excimer laser coronary atherectomy |
1 |
2017 |
| Drug |
exenatide |
1 |
2011 |
| Other |
exercise-based cardiac rehabilitation program |
1 |
2011 |
| Other |
exercise compliance |
1 |
2018 |
| Procedure |
exercise ecg |
1 |
2015 |
| Behavioral |
exercise facilitator intervention |
1 |
2012 |
| Other |
exercise sessions in hybrid program |
1 |
2019 |
| Other |
exercise sessions in standard program |
1 |
2019 |
| Procedure |
exercise stress echocardiography |
1 |
2012 |
| Procedure |
exercise testing - coronary angiography - revascularization |
1 |
2007 |
| Behavioral |
exercise training component |
1 |
2013 |
| Behavioral |
exercise training for 10 weeks |
1 |
2005 |
| Other |
exercise, aerobic (water based) |
1 |
2014 |
| Other |
exercise/cognitive testing |
1 |
2016 |
| Drug |
exercise/regadenoson (lexercise) |
1 |
2010 |
| Other |
exercise/rest/cold/neutral temperature |
1 |
2016 |
| Device |
exosealâ® |
1 |
2011 |
| Drug |
exparel |
1 |
2013 |
| Drug |
exparel injectable product |
1 |
2017 |
| Behavioral |
expectation manipulation intervention |
1 |
2011 |
| Behavioral |
experimental group :tai chi cardiac rehabilitation program |
1 |
2019 |
| Behavioral |
exposure to dilute diesel exhaust (300âµg |
1 |
2007 |
| Behavioral |
exposure to dilute diesel exhaust (300âµg/m3)/filtered air |
1 |
2007 |
| Behavioral |
exposure to sporting events |
1 |
2008 |
| Device |
express2 |
1 |
2006 |
| Behavioral |
extended behavioral intervention |
1 |
2016 |
| Procedure |
external counter pulsation therapy |
1 |
2006 |
| Other |
extracorporeal photopheresis |
1 |
2018 |
| Drug |
ezetimibe ( |
1 |
2005 |
| Drug |
ezetimibe (/) simvastatin |
1 |
2005 |
| Drug |
ezetimibe / atorvastatin |
1 |
2008 |
| Other |
ezetimibe / plant sterols |
1 |
2014 |
| Drug |
ezetimibe 10 mg orally once a day |
1 |
2017 |
| Drug |
ezetimibe 10 mg/simvastatin 20 mg |
1 |
2007 |
| Drug |
ezetimibe 10 mg/simvastatin 40 mg |
1 |
2007 |
| Drug |
ezetimibe 10mg |
1 |
2007 |
| placebo |
ezetimibe placebo |
1 |
2007 |
| Drug |
ezetimibe with simvastatin |
1 |
2018 |
| Drug |
ezetimibe/simvastatin |
1 |
2007 |
| Drug |
ezetimibe/simvastatin 10/20 mg |
1 |
2007 |
| Device |
face mask |
1 |
2008 |
| Behavioral |
familial risk assessment |
1 |
2005 |
| Behavioral |
familial risk assessment/personalized prevention messages |
1 |
2005 |
| Other |
family-oriented primary cardiovascular prevention |
1 |
2018 |
| Drug |
famotidine 40mg twice daily |
1 |
2009 |
| Other |
fan |
1 |
2019 |
| Other |
fan / skin wetting |
1 |
2019 |
| Device |
fantom |
1 |
2018 |
| Device |
fantom sirolimus-eluting coronary bioresorbable scaffold |
1 |
2015 |
| Other |
fast step test with measurement of pulmonary gas exchange |
1 |
2018 |
| Other |
fast step test without measurement of pulmonary gas exchange |
1 |
2018 |
| Device |
fastigial nucleus stimulation |
1 |
2019 |
| Drug |
fdg |
1 |
1999 |
| Device |
fdg pet-mdct |
1 |
2010 |
| Drug |
febuxostat |
1 |
2013 |
| placebo |
febuxostat placebo |
1 |
2013 |
| Behavioral |
feedback friend |
1 |
2014 |
| Procedure |
femoral technical |
1 |
2013 |
| Device |
femosealâ® |
1 |
2011 |
| Drug |
fentanyl, propofol |
1 |
2019 |
| Drug |
ferric carboxymaltose |
1 |
2018 |
| Drug |
ferumoxytol |
1 |
2016 |
| Diagnostic Test |
ffr-based diagnostic strategy |
1 |
2018 |
| Device |
ffr-guided coronary revascularization |
1 |
2018 |
| Device |
ffr-guided pci |
1 |
2018 |
| Device |
ffr-guided pci/tavi |
1 |
2018 |
| Procedure |
ffr-guided revascularisation strategy |
1 |
2011 |
| Procedure |
ffr-guided surgical revascularization |
1 |
2014 |
| Procedure |
ffr (fractional flow reserve) |
1 |
2012 |
| Procedure |
ffr guidance |
1 |
2010 |
| Procedure |
ffr guided pci |
1 |
2014 |
| Device |
ffr infusion microcatheter |
1 |
2015 |
| Device |
ffr infusion microcatheter/standard intra-venous (iv) infusion |
1 |
2015 |
| Other |
ffr measurement |
1 |
2015 |
| Drug |
ffr measurement with iv adenoscanâ® then with regadenoson |
1 |
2011 |
| Device |
ffr measurement, side branch angioplasty |
1 |
2006 |
| Procedure |
ffr treatment arm |
1 |
2016 |
| Other |
ffr via central venous line |
1 |
2010 |
| Other |
ffr via peripheral venous line |
1 |
2010 |
| Other |
ffrct analysis (fractional flow reserve computed tomography) |
1 |
2012 |
| Drug |
fibrinogen |
1 |
2009 |
| Radiation |
field of view |
1 |
2016 |
| Drug |
filgrastim (rg-csf) |
1 |
2008 |
| Behavioral |
filtered air |
1 |
2007 |
| Procedure |
filtrapâ„¢ |
1 |
2011 |
| Procedure |
filtrapâ„¢ / thrombus aspiration catheter |
1 |
2011 |
| Behavioral |
financial incentives |
1 |
2014 |
| Device |
firebird2â® sirolimus eluting stent system |
1 |
2014 |
| Device |
firehawk |
1 |
2010 |
| Device |
firehawk biodegradable polymer rapamycin-eluting stent |
1 |
2011 |
| Device |
firehawkâ„¢ stent system |
1 |
2015 |
| Device |
firehawktm 2.25mm |
1 |
2016 |
| Device |
firesorb |
1 |
2016 |
| Drug |
fish oil emulsion |
1 |
2007 |
| placebo |
fish oil supplementation vs placebo |
1 |
2010 |
| Device |
fitbit charge 2 |
1 |
2019 |
| Drug |
fixed high potent statin therapy |
1 |
2015 |
| Dietary Supplement |
flavanol-rich drink vs flavanol-free drink |
1 |
2015 |
| Other |
flaxseed |
1 |
2017 |
| Device |
floseal |
1 |
2020 |
| Other |
flotrac measurement |
1 |
2016 |
| Device |
fluent (vgs fluent external support device) |
1 |
2011 |
| Procedure |
fluid loading |
1 |
2009 |
| Procedure |
fluid restriction policy |
1 |
2008 |
| Procedure |
fluoroscopic |
1 |
2018 |
| Procedure |
fluoroscopic / ultrasound guidance |
1 |
2018 |
| Other |
fluoroscopy-save group |
1 |
2012 |
| Drug |
flurpiridaz f18 |
1 |
2011 |
| Drug |
fluvastatin |
1 |
2005 |
| Dietary Supplement |
fmd arm |
1 |
2019 |
| Drug |
folic acid, vitamin b12 |
1 |
2008 |
| Drug |
folic acid, vitamin b12 (cyanocobalamin) |
1 |
2006 |
| Drug |
folic acid, vitamin b12 (cyanocobalamin), vitamin b6 (pyridoxine) |
1 |
2006 |
| Drug |
folic acid, vitamin b12/b6/rosuvastatin |
1 |
2008 |
| Drug |
folic acid/vitamin b6/vitamin b12 |
1 |
1999 |
| Procedure |
follow-up coronary angiography |
1 |
2010 |
| Other |
follow-up visit m2 |
1 |
2017 |
| Other |
follow-up vsit m8 |
1 |
2017 |
| Behavioral |
follow up |
1 |
2016 |
| Procedure |
forearm blood flow study |
1 |
2003 |
| Procedure |
forearm radial artery access in coronary angiography |
1 |
2019 |
| Procedure |
forearm radial artery access in coronary angiography/angioplasty |
1 |
2019 |
| Drug |
form 1 of azd5718 tablets |
1 |
2018 |
| Drug |
form 2 of azd5718 tablets |
1 |
2018 |
| Drug |
form 3 of azd5718 tablets |
1 |
2018 |
| Drug |
form 4 of azd5718 tablets |
1 |
2018 |
| Drug |
form 5 of azd5718 tablets |
1 |
2018 |
| Drug |
fospropofol |
1 |
2005 |
| Other |
fraction of inspired oxygen level |
1 |
2019 |
| Device |
fractional flow reserve |
1 |
2005 |
| Procedure |
fractional flow reserve-guided cabg |
1 |
2015 |
| Diagnostic Test |
fractional flow reserve with adenosine stress testing |
1 |
2020 |
| Procedure |
free fluid infusion |
1 |
2008 |
| Other |
full drug coverage |
1 |
2007 |
| Diagnostic Test |
functional assessment of myocardial ischemia by icecg |
1 |
2019 |
| Procedure |
functional testing by fractional flow reserve measurement |
1 |
2013 |
| Drug |
gadobenate dimeglumine |
1 |
2012 |
| Drug |
gadobutrol (gadavist, gadovist, bay86-4875) |
1 |
2013 |
| Drug |
gadobutrol (gadovist, gadavist, bay86-4875) |
1 |
2013 |
| Drug |
gadolinium |
1 |
2010 |
| Drug |
gadoterate meglumine |
1 |
2010 |
| Device |
gamma-iridium-192 catheter |
1 |
2005 |
| Device |
gamma camera |
1 |
2015 |
| Dietary Supplement |
garlic |
1 |
2013 |
| Device |
gated stationary chest tomosynthesis |
1 |
2017 |
| Drug |
gefarnate |
1 |
2018 |
| Device |
gekotm |
1 |
2013 |
| Drug |
gemfibrozil |
1 |
2006 |
| Behavioral |
general sleep education |
1 |
2016 |
| Genetic |
genetic risk counseling |
1 |
2013 |
| Other |
genetic risk score |
1 |
2013 |
| Behavioral |
genetic risk score for coronary risk factors |
1 |
2011 |
| Drug |
genistein |
1 |
2006 |
| Other |
genotype-guided therapy |
1 |
2017 |
| Device |
genous stent implantation |
1 |
2008 |
| Device |
genous stent implantation with paclitaxel-eluting balloon dilation |
1 |
2008 |
| Drug |
ginkgo biloba pills |
1 |
2018 |
| Drug |
glibenclamide 5 mg |
1 |
2016 |
| Device |
glidesheath slender |
1 |
2014 |
| Drug |
glimepiride upto 4 mg oral tablet |
1 |
2018 |
| Drug |
glipizide |
1 |
2007 |
| Other |
glitazon |
1 |
2007 |
| Drug |
glp-1 |
1 |
2014 |
| Drug |
glucose-insulin-potassium |
1 |
2008 |
| Biological |
glucose meter |
1 |
2018 |
| Drug |
glutamine |
1 |
2013 |
| Drug |
glycopyrrolate |
1 |
2019 |
| Behavioral |
go! to sleep |
1 |
2016 |
| Dietary Supplement |
goodbelly probiotic |
1 |
2013 |
| Device |
gracey curettes |
1 |
2015 |
| placebo |
grain flour placebo |
1 |
2016 |
| Drug |
granulocyte colony-stimulating factor (g-csf) |
1 |
2018 |
| Dietary Supplement |
grape seed extract |
1 |
2007 |
| Dietary Supplement |
grape seed extract/ascorbic acid |
1 |
2007 |
| Procedure |
graphic medication schedule (pill card) |
1 |
2005 |
| Behavioral |
group based cognitive therapy |
1 |
2020 |
| Other |
group education |
1 |
2019 |
| Other |
group g10 |
1 |
2018 |
| Other |
group g15 |
1 |
2018 |
| Other |
group g5 |
1 |
2018 |
| Behavioral |
group support |
1 |
2006 |
| Drug |
gs-6615 |
1 |
2013 |
| Drug |
gtn |
1 |
2005 |
| Device |
guidant galileo intravascular radiotherapy system |
1 |
2005 |
| Device |
guide catheter combination |
1 |
2017 |
| Device |
guide exercise (gex-)- training |
1 |
2012 |
| Device |
guided exercise (gex) system |
1 |
2012 |
| Device |
guided exercise training with an easy to wear vest with electrodes to measure ecg, respiration, activity |
1 |
2012 |
| Device |
guidelinerâ® v3 catheter, traplinerâ® catheter, turnpikeâ® catheter |
1 |
2019 |
| Other |
half-dose isotope for nuclearstresstest |
1 |
2012 |
| Other |
handgrip |
1 |
2014 |
| Behavioral |
harp intervention |
1 |
2012 |
| Drug |
hctz |
1 |
2005 |
| Radiation |
hd-ctca with adaptive statistical iterative reconstruction (asir) |
1 |
2013 |
| Behavioral |
health education program |
1 |
2013 |
| Other |
health information prescription |
1 |
2010 |
| Behavioral |
health literacy-based intervention |
1 |
2019 |
| Other |
healthy lifestyles |
1 |
2010 |
| Other |
healthy lifestyles/sleep education |
1 |
2010 |
| Other |
healthy lifestyles/sleep education/pap |
1 |
2010 |
| Other |
healthy lifestyles/sleep education/supplemental oxygen |
1 |
2010 |
| Other |
heart rate |
1 |
2018 |
| Other |
heart rate monitor |
1 |
2012 |
| Behavioral |
heart rate variability (hrv) biofeedback (bf) |
1 |
2016 |
| Procedure |
heart valve surgery |
1 |
2012 |
| Behavioral |
hearthab application intervention |
1 |
2016 |
| Device |
heartmate php |
1 |
2015 |
| Device |
helios biodegradable polymer sirolimus-eluting stents |
1 |
2019 |
| Device |
helistent titan2 (titanium coated stent) |
1 |
2007 |
| Other |
hemodynamic |
1 |
2011 |
| Other |
hemodynamic/biological measurements |
1 |
2011 |
| Drug |
hepalean heparin |
1 |
2011 |
| Drug |
hexadecasaccharide (sr123781a) |
1 |
2005 |
| Drug |
high dose potent statin |
1 |
2018 |
| Drug |
high dose rosuvastatin |
1 |
2017 |
| Dietary Supplement |
high dose vitamin |
1 |
2002 |
| placebo |
high dose vitamin placebo |
1 |
2002 |
| Dietary Supplement |
high energy diet |
1 |
2019 |
| Behavioral |
high intensity interval-based aerobic exercise |
1 |
2015 |
| Behavioral |
high intensity interval training |
1 |
2016 |
| Other |
high intensity interval training (hiit) |
1 |
2013 |
| Drug |
high maintenance clopidogrel |
1 |
2011 |
| Other |
high phytosterol diets |
1 |
2009 |
| Other |
high risk |
1 |
2013 |
| Drug |
hmg-coa reductase inhibitor |
1 |
2011 |
| Drug |
hmg coa inhibitor |
1 |
2006 |
| Other |
hold hypoglycemic meds |
1 |
2011 |
| Other |
home-based cardiac rehabilitation |
1 |
2017 |
| Other |
home-based cr |
1 |
2018 |
| Behavioral |
home-based training with telemonitoring guidance |
1 |
2014 |
| Other |
home cardiac rehabilitation |
1 |
2018 |
| Other |
home cardiac rehabilitation/respiratory rehabilitation |
1 |
2018 |
| Other |
hospital-based cr |
1 |
2018 |
| Other |
hospital-based cr / movn application |
1 |
2018 |
| Other |
hospital-based cr / movn application / nudge |
1 |
2018 |
| Drug |
hs-25 |
1 |
2018 |
| Drug |
hs-25/atorvastatin |
1 |
2018 |
| Biological |
human allogeneic mesenchymal bone marrow cells (ambmc) |
1 |
2019 |
| Biological |
human embryonic stem cell-derived cd15 |
1 |
2013 |
| Biological |
human embryonic stem cell-derived cd15/ isl-1/ progenitors |
1 |
2013 |
| Drug |
humanalbumin 5% |
1 |
2010 |
| Drug |
humulin r |
1 |
2016 |
| Other |
hvbh with oxygen |
1 |
2014 |
| Procedure |
hybrid (midcab |
1 |
2012 |
| Procedure |
hybrid (midcab/pci) |
1 |
2012 |
| Procedure |
hybrid cabg |
1 |
2009 |
| Procedure |
hybrid cabg/pci |
1 |
2009 |
| Behavioral |
hycr |
1 |
2018 |
| Drug |
hydrochlorothiazide (hctz) |
1 |
2005 |
| Drug |
hydrocortisone |
1 |
2006 |
| Drug |
hydroxychloroquine |
1 |
2019 |
| Drug |
hypertonic sodium lactate |
1 |
2012 |
| Other |
hyperventilation breath-hold (hvbh) |
1 |
2014 |
| Procedure |
iabp |
1 |
2009 |
| Drug |
ibuprofen |
1 |
2007 |
| Procedure |
ica (invasive coronary angiography) |
1 |
2012 |
| Behavioral |
icdm |
1 |
2011 |
| Device |
ifr pullback with syncvision software (volcano company) |
1 |
2020 |
| Other |
illness history |
1 |
2016 |
| Other |
image quality |
1 |
2014 |
| Procedure |
immediate complete pci |
1 |
2017 |
| Procedure |
immediate rotational atherectomy (ra) |
1 |
2012 |
| Behavioral |
impact of coronary images used during patient education on coronary artery disease |
1 |
2011 |
| Behavioral |
impact of coronary images used during patient education on coronary artery disease/subsequent lifestyle modifications |
1 |
2011 |
| Drug |
impact on vasp test |
1 |
2006 |
| Device |
impella cp pvad |
1 |
2017 |
| Device |
implantable cardioverter defibrillator |
1 |
2014 |
| Device |
implantation of a bare metal stent |
1 |
2010 |
| Device |
implantation of a sirolimus-eluting resorbable coronary magnesium scaffold |
1 |
2019 |
| Device |
implantation of biolimus-eluting stents |
1 |
2012 |
| Device |
implantation of cep magna ease model 3300tfx |
1 |
2010 |
| Procedure |
implantation of coronary stent in bifurcation lesion |
1 |
2011 |
| Device |
implantation of everolimus-eluting bioresorbable vascular scaffold stent |
1 |
2012 |
| Device |
implantation of everolimus-eluting coronary stent |
1 |
2008 |
| Device |
implantation of everolimus-eluting stents |
1 |
2012 |
| Device |
implantation of kaname cobalt-chromium coronary stent |
1 |
2009 |
| Device |
implantation of sirolimus-eluting coronary stent |
1 |
2008 |
| Procedure |
in-situ |
1 |
2018 |
| Procedure |
in-vitro hemodilution |
1 |
2017 |
| Other |
in hospital cardiopulmonary rehabilitation |
1 |
2009 |
| Device |
incentive spirometer |
1 |
2016 |
| Behavioral |
increasing awareness to cardiac rehabilitation programs |
1 |
2006 |
| Behavioral |
individual feedback |
1 |
2014 |
| Procedure |
indocyanine green intraoperative angiogram |
1 |
2005 |
| Procedure |
indocyanine green intraoperative angiogram/transit-time flowmetry |
1 |
2005 |
| Drug |
infiltration of surgical wounds with local anaesthetic |
1 |
2018 |
| Biological |
influenza vaccination: influvac (solvaypharma) |
1 |
2006 |
| Behavioral |
information |
1 |
2012 |
| Behavioral |
information / attention comparison |
1 |
2012 |
| Behavioral |
information control |
1 |
2007 |
| Behavioral |
information session |
1 |
2008 |
| Drug |
inhalational anesthetic |
1 |
2006 |
| Other |
inhaled anaesthetic agent |
1 |
2012 |
| Drug |
inhibition of platelet aggregation by “brilinta”(ticagrelor) |
1 |
2014 |
| Drug |
injection of adrc’s |
1 |
2007 |
| placebo |
injection of placebo |
1 |
2007 |
| Drug |
inopulse delivery system |
1 |
2001 |
| Other |
inspirator muscle training |
1 |
2018 |
| Device |
inspiron stent |
1 |
2012 |
| Drug |
insulin glargine |
1 |
2015 |
| Behavioral |
int |
1 |
2016 |
| Behavioral |
integrated cardiovascular disease risk management. |
1 |
2016 |
| Behavioral |
integration of a team based clinical pharmacist |
1 |
2006 |
| Device |
intelligent terminal app |
1 |
2018 |
| Other |
intensive control |
1 |
2011 |
| Behavioral |
intensive exercise training |
1 |
2010 |
| Behavioral |
intensive training |
1 |
2014 |
| Procedure |
intentional strategy |
1 |
2015 |
| Behavioral |
interactive voice response |
1 |
2007 |
| Procedure |
intermittent coronary sinus occlusion |
1 |
2012 |
| Device |
intermittent pneumatic compression of the lower extremities |
1 |
2010 |
| Behavioral |
internet-based counselling |
1 |
2019 |
| Procedure |
intervention (pci) |
1 |
2006 |
| Other |
intervention group |
1 |
2015 |
| Drug |
intra-coronary infusion |
1 |
2006 |
| Other |
intracoronary acetylcholine provocation test |
1 |
2009 |
| Procedure |
intracoronary bone marrow cell transfer |
1 |
2005 |
| Device |
intracoronary stent implantation |
1 |
2008 |
| Procedure |
intramyocardial implantation of of a novel mesenchymal precursor cell type (imp). |
1 |
2012 |
| Procedure |
intramyocardial injection of autologous cd133 |
1 |
2007 |
| Procedure |
intramyocardial injection of autologous cd133/ marrow cells |
1 |
2007 |
| Genetic |
intramyocardial injection of vegf-a165 |
1 |
2008 |
| Genetic |
intramyocardial injection of vegf-a165/bfgf:placebo plasmid |
1 |
2008 |
| Genetic |
intramyocardial vegf angiogenesis (at a dose of 2 mg) |
1 |
2005 |
| Device |
intravascular imaging (ivus |
1 |
2017 |
| Device |
intravascular imaging (ivus/oct) |
1 |
2017 |
| Procedure |
intravascular ultrasound of the coronary artery. |
1 |
2012 |
| Procedure |
intravenous analgesia |
1 |
2011 |
| Drug |
intravenous anesthetic, propofol |
1 |
2006 |
| Drug |
intravenous dexamethasone intra-operatively |
1 |
2018 |
| Other |
intravenous fluid challenge |
1 |
2019 |
| Other |
intravenous glutamate infusion |
1 |
2007 |
| Drug |
intravenous infusion of saline |
1 |
2007 |
| Drug |
intravenous magnesium intra-operatively |
1 |
2018 |
| Drug |
intravenous ondansetron intra-operatively |
1 |
2018 |
| Drug |
intravenous paracetamol intra-operatively |
1 |
2018 |
| Drug |
intravenous sedatives |
1 |
2017 |
| Procedure |
invasive coronary angiography (ica) |
1 |
2015 |
| Procedure |
invasive coronary treatment |
1 |
2019 |
| Device |
investigational device |
1 |
2013 |
| Device |
invos |
1 |
2009 |
| Drug |
iodixanol |
1 |
2013 |
| Drug |
iodixanol 320 |
1 |
2006 |
| Drug |
iodixanol 320 mg i |
1 |
2005 |
| Drug |
iodixanol 320 mg i/ml |
1 |
2005 |
| Drug |
iodixanol 320 mgi |
1 |
2005 |
| Drug |
iodixanol 320 mgi/ml |
1 |
2005 |
| Drug |
iomeprol |
1 |
2010 |
| Drug |
iomeprol 350 |
1 |
2006 |
| Drug |
iopromide |
1 |
2010 |
| Drug |
ioxaglate |
1 |
2013 |
| Other |
iphone artery assessment |
1 |
2015 |
| Dietary Supplement |
ipp |
1 |
2009 |
| Procedure |
ischemia driven revascularization |
1 |
2018 |
| Biological |
isl-1 |
1 |
2013 |
| Drug |
isoflurane 1.0 mac |
1 |
2013 |
| Drug |
isoflurane 1.5 mac |
1 |
2013 |
| Drug |
isoflurane 2.0 mac |
1 |
2013 |
| Drug |
isoflurane, sevoflurane |
1 |
2019 |
| Drug |
isoflurane, sevoflurane/desflurane |
1 |
2019 |
| Other |
isometric exercise |
1 |
2014 |
| Other |
isometric handgrip training (iso) |
1 |
2017 |
| Drug |
isosorbide dinitrate |
1 |
2012 |
| Drug |
isosorbide dinitrate 10mg tablet |
1 |
2016 |
| Drug |
isosorbite mononitrate |
1 |
2017 |
| Drug |
isosorbite mononitrate (ismn) |
1 |
2017 |
| Drug |
isovue 370, 70 ml |
1 |
2007 |
| Drug |
isovue 370, 80 ml |
1 |
2007 |
| Drug |
isovue 370, 90 ml |
1 |
2007 |
| Device |
itpr |
1 |
2010 |
| Drug |
iv isotonic bicarbonate |
1 |
2011 |
| Drug |
iv isotonic saline |
1 |
2011 |
| Device |
ivac2l pvad |
1 |
2017 |
| Device |
ivl coronary lithotripsy system |
1 |
2017 |
| Device |
ivus-guided pci |
1 |
2013 |
| Device |
ivus-guided pci/ofdi |
1 |
2013 |
| Device |
ivus guidance |
1 |
2020 |
| Procedure |
ivus guided percutaneous coronary angioplasty with resolute integrity stent insertion |
1 |
2013 |
| Device |
jactax des |
1 |
2008 |
| Device |
jactax drug eluting stent |
1 |
2008 |
| Device |
jactax ld des |
1 |
2008 |
| Device |
jactax ld drug eluting stent |
1 |
2008 |
| Procedure |
jailed wire technique |
1 |
2018 |
| Device |
janus stent |
1 |
2006 |
| Device |
judkins 3.5l |
1 |
2017 |
| Device |
judkins 3.5l/4r cardiac catheters |
1 |
2017 |
| Drug |
kardogrel |
1 |
2010 |
| Drug |
keep dapt |
1 |
2012 |
| Drug |
kg |
1 |
2015 |
| Procedure |
kissing balloon |
1 |
2008 |
| Dietary Supplement |
konjac glucomannan |
1 |
2018 |
| Dietary Supplement |
l-arg supplement |
1 |
2018 |
| Dietary Supplement |
l-arginine |
1 |
2007 |
| Dietary Supplement |
l-arginine/creatine |
1 |
2007 |
| Other |
laboratory biomarker analysis |
1 |
2014 |
| Other |
land-based exercise training |
1 |
2016 |
| Procedure |
laryngoscopy |
1 |
2010 |
| Device |
late deflation of tr band |
1 |
2017 |
| Procedure |
lateral femoral cutaneous nerve blocks |
1 |
2017 |
| Dietary Supplement |
lc-1000 |
1 |
2013 |
| Dietary Supplement |
lc-2000 |
1 |
2013 |
| Drug |
lde-paclitaxel |
1 |
2019 |
| placebo |
lde-placebo |
1 |
2019 |
| Procedure |
left circumflex coronary artery territories |
1 |
2005 |
| Other |
leg exercise |
1 |
2014 |
| Drug |
leuprolide acetate |
1 |
2012 |
| Drug |
levosimendan |
1 |
2005 |
| Drug |
levosimendan infusion |
1 |
2011 |
| Drug |
lexiscan |
1 |
2017 |
| Device |
libertã© |
1 |
2009 |
| Drug |
lidocaine |
1 |
2016 |
| Behavioral |
lifestyle modification |
1 |
2010 |
| Behavioral |
lifestyle physical activity intervention |
1 |
2012 |
| Behavioral |
lifestyle recommendations |
1 |
2016 |
| Behavioral |
lifestyle/medication intervention |
1 |
2010 |
| Procedure |
lima to svg bridge technique |
1 |
2012 |
| Drug |
linagliptin |
1 |
2015 |
| Device |
lipiscan |
1 |
2012 |
| Device |
lipiscan coronary imaging catheter |
1 |
2009 |
| Device |
lipiscan ivus |
1 |
2012 |
| Device |
lipiscan/lipiscan ivus |
1 |
2012 |
| Drug |
lipitor (atorvastatin) monotherapy |
1 |
2010 |
| Drug |
liraglutide pen injector [victoza] |
1 |
2017 |
| Behavioral |
lite |
1 |
2014 |
| Device |
lithoplasty |
1 |
2020 |
| Drug |
local anaesthetic injection |
1 |
2017 |
| Drug |
local anesthetic |
1 |
2017 |
| Procedure |
long introducer sheath |
1 |
2019 |
| Drug |
louxiangdan tongxin granules |
1 |
2011 |
| Procedure |
low-dose dobutamine tc-99-m-mibi gated spect imaging |
1 |
2007 |
| Other |
low-dose stress mpi spect |
1 |
2011 |
| Drug |
low-dose ticagrelor |
1 |
2018 |
| Device |
low level laser hemotherapy |
1 |
2018 |
| Other |
low phytosterol |
1 |
2009 |
| Other |
low phytosterol/high phytosterol diets |
1 |
2009 |
| Other |
lung ventilation |
1 |
2012 |
| Drug |
m118 |
1 |
2007 |
| Behavioral |
m3) |
1 |
2007 |
| Device |
magic-touch drug-eluting balloon |
1 |
2015 |
| Device |
magmaris |
1 |
2016 |
| Drug |
magnesium l-lactate |
1 |
2006 |
| Drug |
magnesium sulfate |
1 |
2018 |
| Procedure |
magnetic resonance imaging (mri) |
1 |
2016 |
| Device |
magnetocardiograph |
1 |
2005 |
| Behavioral |
mailed dvd |
1 |
2012 |
| Other |
maintenance of physical exercise |
1 |
2019 |
| Procedure |
mammarioradial graft (y-graft) |
1 |
2013 |
| Behavioral |
management of stress |
1 |
2020 |
| Procedure |
marrow cells |
1 |
2007 |
| placebo |
matching liraglutide-placebo pre-filled pens |
1 |
2017 |
| placebo |
matching placebo |
1 |
2009 |
| Biological |
mcrciâ® stem cells |
1 |
2019 |
| Procedure |
mdct |
1 |
2007 |
| Procedure |
mdct calcium score |
1 |
2006 |
| Procedure |
mdct of the coronary arteries. |
1 |
2006 |
| Procedure |
mdct/coronary angiography |
1 |
2007 |
| Device |
mdt-4107 drug eluting stent |
1 |
2009 |
| Device |
mdt-4107 zotarolimus-eluting coronary stent |
1 |
2010 |
| Procedure |
measure of hemodynamic indices in a stenosed coronary artery using a pressure wire |
1 |
2019 |
| Other |
measure of psychiatric condition |
1 |
2016 |
| Other |
measure of social conditions |
1 |
2016 |
| Drug |
medi5884 |
1 |
2017 |
| Biological |
medi6012 |
1 |
2015 |
| Device |
medical device hemopatch-peg-coated collagen patch |
1 |
2017 |
| Behavioral |
medication compliance |
1 |
2005 |
| Other |
medication education tool |
1 |
2006 |
| Behavioral |
medication intervention |
1 |
2010 |
| Behavioral |
medication review |
1 |
2014 |
| Procedure |
meditation |
1 |
2001 |
| Behavioral |
medium-intensity minimally-directive counseling |
1 |
2006 |
| Drug |
medroxyprogesterone |
1 |
1999 |
| Drug |
medroxyprogesterone 17-acetate |
1 |
2004 |
| Drug |
medroxyprogesterone 2.5 mg daily |
1 |
2006 |
| Device |
medtronic bifurcation stent system |
1 |
2008 |
| Device |
medtronic coronary drug-coated balloon catheter |
1 |
2017 |
| Device |
medtronic endeavor coronary stent system |
1 |
2008 |
| Device |
medtronic endeavor resolute |
1 |
2008 |
| Device |
medtronic resolute onyx zotarolimus-eluting coronary stent system |
1 |
2017 |
| Drug |
melatonin 3 mg |
1 |
2019 |
| Dietary Supplement |
menaquinone-7 (vitamin k2) |
1 |
2009 |
| Other |
mental stress protocol |
1 |
2016 |
| Diagnostic Test |
mental stress test |
1 |
2019 |
| Device |
meres100 sirolimus eluting bioresorbable vascular scaffold system |
1 |
2015 |
| Genetic |
mesenchymal stem cells |
1 |
2010 |
| Device |
mesh |
1 |
2013 |
| Drug |
metformin 1000 mg oral tablet |
1 |
2018 |
| Drug |
metformin only |
1 |
2012 |
| Drug |
metformin xl |
1 |
2014 |
| Drug |
metformin, glimepiride, insulin |
1 |
2007 |
| Drug |
metformin/vildagliptin |
1 |
2012 |
| Drug |
methylnaltrexone |
1 |
2015 |
| Behavioral |
mgt |
1 |
2005 |
| Other |
mhealth-cr |
1 |
2019 |
| Behavioral |
mi |
1 |
2014 |
| Behavioral |
mi/medication review |
1 |
2014 |
| Procedure |
mics cabg |
1 |
2018 |
| Drug |
midazolam |
1 |
2016 |
| Drug |
milrinone |
1 |
2009 |
| Drug |
min |
1 |
2015 |
| Behavioral |
mindfulness based stress reduction |
1 |
2013 |
| Behavioral |
mindfulness based stress reduction (mbsr) |
1 |
2017 |
| Behavioral |
mindfulness based stress reduction class |
1 |
2005 |
| Procedure |
mini-crush stenting |
1 |
2016 |
| Procedure |
miniaturized extracorporeal circulation |
1 |
2017 |
| Procedure |
minimally invasive bypass surgery |
1 |
2005 |
| Device |
mio slice |
1 |
2019 |
| Drug |
mipomersen |
1 |
2008 |
| Drug |
misoprostol |
1 |
2014 |
| Device |
mistent |
1 |
2015 |
| Device |
mistent (mt005) coronary artery stent |
1 |
2016 |
| Device |
mistent des |
1 |
2011 |
| Device |
mistent ses |
1 |
2010 |
| Procedure |
mitral valve repair |
1 |
2008 |
| Procedure |
mitral valve repair with annuloplasty |
1 |
2008 |
| Procedure |
mitral valve replacement |
1 |
2008 |
| Drug |
ml [praluent] |
1 |
2018 |
| Drug |
ml [repatha] |
1 |
2019 |
| Behavioral |
mobile application |
1 |
2017 |
| Behavioral |
mobile health application |
1 |
2015 |
| Behavioral |
moderate consumption of fruit juice rich in polyphenolics |
1 |
2006 |
| Other |
moderate continuous exercise training |
1 |
2014 |
| Behavioral |
moderate continuous training |
1 |
2010 |
| Behavioral |
moderate daily consumption of beer |
1 |
2006 |
| Behavioral |
moderate daily consumption of red wine |
1 |
2006 |
| Behavioral |
moderate intensity continuous training |
1 |
2017 |
| Drug |
modified-release dipyridamole |
1 |
2005 |
| Drug |
modified-release dipyridamole/aspirin |
1 |
2005 |
| Diagnostic Test |
modified allen’s test |
1 |
2019 |
| Other |
modified allen test |
1 |
2015 |
| Procedure |
modified ultrafiltration |
1 |
2010 |
| Device |
modular cardiopulmonary bypass circuit |
1 |
2013 |
| Drug |
molsidomine |
1 |
2006 |
| Other |
mononuclear cells from autologous bone marrow |
1 |
2013 |
| Drug |
montelukast |
1 |
2006 |
| Drug |
morphine |
1 |
2015 |
| Other |
motivational interviewing (mi) |
1 |
2019 |
| Behavioral |
motivational interviewing (mint) |
1 |
2012 |
| Behavioral |
motivational social support from nurse |
1 |
2019 |
| Behavioral |
motivational social support from nurse with additional support from significant other |
1 |
2019 |
| Behavioral |
movie |
1 |
2012 |
| Behavioral |
moving |
1 |
2005 |
| Other |
movn application |
1 |
2018 |
| Behavioral |
movn mobile app |
1 |
2018 |
| Drug |
mpsk3169a |
1 |
2012 |
| Procedure |
mr |
1 |
2009 |
| Other |
mr-only imaging on biograph mmr scanner |
1 |
2014 |
| Procedure |
mr imaging of the coronary arteries |
1 |
2006 |
| Other |
mr imaging on the siemens vida 3t mr scanner |
1 |
2014 |
| Procedure |
mr perfusion guidance |
1 |
2010 |
| Other |
mr scan |
1 |
2016 |
| Procedure |
mri |
1 |
2008 |
| Procedure |
ms-ct coronary angiography |
1 |
2006 |
| Biological |
msc |
1 |
2011 |
| Behavioral |
multi-disciplinary disease management approach |
1 |
2009 |
| Procedure |
multidetector computed tomography |
1 |
2011 |
| Other |
multidetector computed tomography - 64 detectors |
1 |
2008 |
| Procedure |
multidetector computed tomography coronary angiography |
1 |
2006 |
| Radiation |
multidetector computed tomography scanning |
1 |
2007 |
| Behavioral |
multidisciplinary palliative care team met with patient |
1 |
2006 |
| Procedure |
multiple-pass hemofiltration |
1 |
2011 |
| Procedure |
multiple arterial grafting |
1 |
2017 |
| Other |
music therapy |
1 |
2012 |
| Procedure |
myocardial contrast echocardiography |
1 |
1999 |
| Procedure |
myocardial ct perfusion |
1 |
2014 |
| Device |
myocardial iq-spect imaging applied to scintigraphic imaging |
1 |
2015 |
| Procedure |
myocardial perfusion imaging |
1 |
2009 |
| Procedure |
myocardial perfusion imaging scan |
1 |
2007 |
| Device |
myocardial perfusion mri |
1 |
2013 |
| Other |
myocardial perfusion scan |
1 |
2017 |
| Procedure |
myocardial protection techniques |
1 |
2005 |
| Device |
myovista device |
1 |
2015 |
| Drug |
n-13 ammonia |
1 |
2011 |
| Drug |
n-hydroxy-nor-arginine |
1 |
2013 |
| Drug |
n(2)-l-alanine l-glutamine dipeptide |
1 |
2011 |
| Drug |
nacl |
1 |
2013 |
| Behavioral |
navigation by a health worker |
1 |
2007 |
| Device |
nc balloon |
1 |
2019 |
| Other |
ncep step 1 diet |
1 |
2009 |
| Other |
ncep step 1 diet/almonds |
1 |
2009 |
| Drug |
nebivolol |
1 |
2008 |
| Drug |
neostigmine |
1 |
2019 |
| Drug |
nesiritide |
1 |
2008 |
| Behavioral |
network construction |
1 |
2019 |
| Other |
neutral temperature |
1 |
2016 |
| Drug |
nh(3) |
1 |
1999 |
| Drug |
niacin/laropiprant |
1 |
2010 |
| Drug |
niaspan |
1 |
2007 |
| Dietary Supplement |
nicotinamide riboside (nr) |
1 |
2016 |
| Drug |
nicotine patch |
1 |
2017 |
| Drug |
nifedipine |
1 |
2005 |
| Device |
nirs/ivus |
1 |
2016 |
| Device |
nirx(tm) paclitaxel-coated conformer coronary stent system |
1 |
2006 |
| Drug |
nitrates, clopidogrel, aspirin, statins |
1 |
2010 |
| Drug |
nitric oxide/inopulse delivery system |
1 |
2001 |
| Drug |
nitrous oxide/placebo |
1 |
2008 |
| Device |
no-numoâ„¢ high vacuum body cavity drainage system |
1 |
2007 |
| Procedure |
no-touch svg harvest vs conventional svg harvest technique |
1 |
2010 |
| Other |
no almonds |
1 |
2009 |
| Behavioral |
no exposure to sporting events |
1 |
2008 |
| Device |
no face mask |
1 |
2008 |
| Other |
no ischemic preconditioning |
1 |
2015 |
| Behavioral |
no moving |
1 |
2005 |
| Other |
no nitrous oxide |
1 |
2007 |
| Other |
no physical activity monitors |
1 |
2010 |
| Diagnostic Test |
no routine stress testing |
1 |
2017 |
| Other |
no screening |
1 |
2018 |
| Drug |
non-arb |
1 |
2005 |
| Other |
non-pet medical management |
1 |
2019 |
| Other |
non-ventilated group |
1 |
2012 |
| Other |
non invasive cardiac imaging |
1 |
2009 |
| Other |
non periodized exercise training regime |
1 |
2017 |
| Other |
noninvasive ventilation |
1 |
2016 |
| Behavioral |
nordic walking |
1 |
2016 |
| Drug |
normal saline flush, 0.9% injectable solution |
1 |
2018 |
| Drug |
normal saline solution |
1 |
2011 |
| Other |
notices |
1 |
2009 |
| Drug |
novel strategy aspirin |
1 |
2015 |
| Device |
noya cocr biodegradable coating sirolimus-eluting stent system |
1 |
2014 |
| Device |
nse balloon |
1 |
2019 |
| Behavioral |
nutritional |
1 |
2008 |
| Behavioral |
nutritional/behavioral program a |
1 |
2008 |
| Behavioral |
nutritional/behavioral program b |
1 |
2008 |
| Dietary Supplement |
nuts |
1 |
2014 |
| Drug |
oac alone |
1 |
2013 |
| Procedure |
obturator nerve blocks |
1 |
2017 |
| Device |
oct |
1 |
2016 |
| Device |
oct-guided paclitaxel drug-coated balloon angioplasty |
1 |
2020 |
| Device |
oct-guided pci |
1 |
2018 |
| Device |
oct-guided pci with ees |
1 |
2012 |
| Device |
oct-guided pci with ees/bes |
1 |
2012 |
| Procedure |
oct-pci |
1 |
2018 |
| Device |
oct guide |
1 |
2012 |
| Device |
oct) |
1 |
2017 |
| Device |
oct/cmr imaging |
1 |
2016 |
| Other |
octa (angiography by tomography in optical coherence) |
1 |
2018 |
| Device |
ofdi-guided pci |
1 |
2013 |
| Device |
ofdi-guided pci/ivus |
1 |
2013 |
| Device |
ofdi imaging |
1 |
2007 |
| Procedure |
off-pump bypass surgery |
1 |
2011 |
| Other |
off-pump cabg |
1 |
2018 |
| Procedure |
off-pump cabg. |
1 |
2018 |
| Procedure |
off-pump coronary-artery bypass grafting |
1 |
2014 |
| Procedure |
off-pump coronary artery bypass grafting |
1 |
2005 |
| Procedure |
off pump cabg |
1 |
2009 |
| Dietary Supplement |
olive oil |
1 |
2014 |
| Drug |
omacor (omega-3-acid ethyl esters) |
1 |
2007 |
| Drug |
omega-3-acid ethyl esters 90 |
1 |
2006 |
| Dietary Supplement |
omega-3 fatty acid supplement |
1 |
2009 |
| Drug |
omega 3 |
1 |
2012 |
| Dietary Supplement |
omega 3 acid ethyl esters |
1 |
2012 |
| Device |
omegaâ„¢ monorail coronary stent system |
1 |
2011 |
| Drug |
omeprazole |
1 |
2013 |
| Drug |
omeprazole, 20mg twice daily |
1 |
2009 |
| Drug |
omnipaque |
1 |
2013 |
| Procedure |
on-pump bypass surgery |
1 |
2011 |
| Other |
on-pump cabg |
1 |
2018 |
| Procedure |
on-pump cabg. |
1 |
2018 |
| Procedure |
on-pump coronary-artery bypass grafting |
1 |
2014 |
| Other |
once ounce per day of walnuts |
1 |
2013 |
| Device |
one-catheter concept |
1 |
2016 |
| Device |
one stent technique |
1 |
2013 |
| Device |
one stent technique / elective fkb |
1 |
2013 |
| Device |
one stent technique alone |
1 |
2013 |
| Behavioral |
online decision aid |
1 |
2016 |
| Procedure |
opcabg with partial clamp |
1 |
2017 |
| Procedure |
opcabg with partial clamp applying carbon dioxide |
1 |
2017 |
| Procedure |
open radial artery harvest |
1 |
2013 |
| Other |
open vein harvest |
1 |
2019 |
| Behavioral |
opinion leader generated |
1 |
2005 |
| Behavioral |
opinion leader generated/endorsed evidence summaries |
1 |
2005 |
| Device |
opn strategy |
1 |
2018 |
| Device |
optical coherence tomography |
1 |
2014 |
| Device |
optical coherence tomography-guided pci with bioresorbable vascular scaffold |
1 |
2015 |
| Device |
optical coherence tomography (c7 xr dragonfly ) |
1 |
2012 |
| Device |
optical coherence tomography evaluations |
1 |
2017 |
| Other |
optimal medical therapy (omt) |
1 |
2014 |
| Drug |
optimal medical treatment |
1 |
2014 |
| Drug |
optimal medicamentous treatment |
1 |
2016 |
| Drug |
optimarkâ® |
1 |
2013 |
| Procedure |
optimisation of the result of intracoronary stenting according to specific algorithm |
1 |
2016 |
| Drug |
optimizing asa |
1 |
2010 |
| Drug |
optimizing asa/clopidogrel treatment |
1 |
2010 |
| Behavioral |
optimizing processes of care |
1 |
2006 |
| Drug |
optimizing therapeutic treatments |
1 |
2006 |
| Drug |
or p2y12 receptor inhibitor) |
1 |
2019 |
| Drug |
oral gabapentin pre-op |
1 |
2018 |
| Drug |
oral hypoglycemic agents |
1 |
2009 |
| Drug |
oral l-arginine supplementation (at a dose of 6 g |
1 |
2005 |
| Drug |
oral l-arginine supplementation (at a dose of 6 g/day) |
1 |
2005 |
| Drug |
oral lansoprazole pre-op |
1 |
2018 |
| Device |
oral prophylaxis |
1 |
2012 |
| Drug |
oral sirolimus |
1 |
2007 |
| Device |
orbital atherectomy |
1 |
2017 |
| Device |
orbital atherectomy system (oas) |
1 |
2016 |
| Other |
organic atlas cedar wood essential oil (cedrus atantica) |
1 |
2019 |
| Device |
orsiro - drug eluting coronary stent |
1 |
2010 |
| Device |
orsiro des |
1 |
2015 |
| Device |
orsiro drug eluting stent |
1 |
2014 |
| Other |
orthostatic group |
1 |
2015 |
| Device |
osiro hybrid drug-eluting stent |
1 |
2013 |
| Other |
other: multidetector computed tomography - 320 detectors |
1 |
2009 |
| Behavioral |
out-patient rehabilitation at the hospital |
1 |
2006 |
| Drug |
overencapsulated caffeine |
1 |
2009 |
| Drug |
oxycodone 10mg |
1 |
2019 |
| Device |
oxycon mobile |
1 |
2019 |
| Drug |
oxygen gas |
1 |
2017 |
| Drug |
oxytocin |
1 |
2008 |
| Drug |
ozone |
1 |
2018 |
| Procedure |
p.i.o.s. |
1 |
2017 |
| Diagnostic Test |
p2ry12 assay |
1 |
2018 |
| Drug |
p2y12 antagonist monotherapy |
1 |
2014 |
| Device |
paclitaxel-eluting stent (taxus) |
1 |
2008 |
| Device |
paclitaxel-eluting taxus(tm) |
1 |
2005 |
| Device |
paclitaxel coated balloon catheter |
1 |
2006 |
| Device |
paclitaxel eluting balloon catheter |
1 |
2018 |
| Device |
paclitaxel eluting ptca balloon catheter (sequent please) |
1 |
2008 |
| Device |
paclitaxel eluting taxus stent (boston scientific) |
1 |
2008 |
| Drug |
paclitaxel nanoparticle albumin bound |
1 |
2004 |
| Behavioral |
paco intervention for avr patients |
1 |
2018 |
| Behavioral |
paco intervention for cabg patients |
1 |
2018 |
| Behavioral |
paco intervention for mvr patients |
1 |
2018 |
| Drug |
pactimibe, cs-505 |
1 |
2005 |
| Drug |
padma 28 |
1 |
2012 |
| Behavioral |
paleolithic diet vs mediterranean diet |
1 |
2007 |
| Procedure |
palpation |
1 |
2012 |
| Drug |
pantoprazole 40mg once daily |
1 |
2009 |
| Other |
pap |
1 |
2010 |
| Procedure |
papillary muscle approximation |
1 |
2017 |
| Drug |
paracetamol |
1 |
2007 |
| Behavioral |
participatory patient care planning |
1 |
2016 |
| Behavioral |
partners together in health (path) intervention |
1 |
2009 |
| Device |
pas-port automated proximal anastomosis system |
1 |
2006 |
| Procedure |
passive leg raising (45 degree leg elevation for 1-2 min) |
1 |
2010 |
| Other |
patent hemostasis |
1 |
2011 |
| Other |
patent hemostasis/heparin |
1 |
2011 |
| Procedure |
patient-controlled epidural analgesia |
1 |
2011 |
| Other |
patient-targeted feedback |
1 |
2013 |
| Drug |
paxil-cr |
1 |
2005 |
| Device |
pcb ptca |
1 |
2019 |
| Procedure |
pci- drug eluting stents |
1 |
2006 |
| Device |
pci for in-bioresorbable scaffold stenosis |
1 |
2017 |
| Other |
pci on the basis of coronary angiography |
1 |
2010 |
| Device |
pci with bes under angio-guide |
1 |
2012 |
| Device |
pci with bes under angio-guide/oct guide |
1 |
2012 |
| Combination Product |
pci with biomatrix alphaâ„¢ stent |
1 |
2019 |
| Combination Product |
pci with comboâ„¢ stent |
1 |
2019 |
| Procedure |
pci with des |
1 |
2005 |
| Device |
pci with dynamic coronary roadmap |
1 |
2019 |
| Device |
pci with ees under angio-guide |
1 |
2012 |
| Device |
pci with ees under angio-guide/oct guide |
1 |
2012 |
| Procedure |
pci with ivus guidance |
1 |
2011 |
| Device |
pci without dynamic coronary roadmap |
1 |
2019 |
| Procedure |
pci without ivus guidance |
1 |
2011 |
| Procedure |
pci) |
1 |
2012 |
| Device |
pe |
1 |
2013 |
| Device |
pe/investigational device |
1 |
2013 |
| Procedure |
pedicled lima |
1 |
2018 |
| Behavioral |
peer mentor |
1 |
2015 |
| Biological |
pegfilgrastim |
1 |
2009 |
| Drug |
pentoxifylline |
1 |
2012 |
| Procedure |
percutaneous coronary angioplasty |
1 |
2006 |
| Procedure |
percutaneous coronary angioplasty/intervention (pci) |
1 |
2006 |
| Device |
percutaneous coronary intervention (dreams) stenting |
1 |
2013 |
| Device |
percutaneous coronary intervention (ng promus) |
1 |
2012 |
| Device |
percutaneous coronary intervention (pci) with paclitaxel-eluting stent (taxus express) placement |
1 |
2007 |
| Device |
percutaneous coronary intervention (xience v stent) |
1 |
2007 |
| Device |
percutaneous coronary intervention biotronik orsiro des |
1 |
2011 |
| Procedure |
percutaneous coronary intervention for complex lesion |
1 |
2017 |
| Procedure |
percutaneous coronary intervention using bare metal stents |
1 |
2014 |
| Procedure |
percutaneous coronary intervention using drug eluting stents |
1 |
2014 |
| Device |
percutaneous coronary intervention using r-one assistance |
1 |
2019 |
| Device |
percutaneous coronary intervention with implantation of amphilimus-eluting stents for coronary artery disease. |
1 |
2019 |
| Device |
percutaneous coronary intervention with implantation of everolimus-eluting stents for coronary artery disease. |
1 |
2019 |
| Device |
percutaneous coronary intervention with new generation fully resorbable scaffold |
1 |
2015 |
| Device |
percutaneous coronary intervention with nobori biolimus-eluting stent implantation |
1 |
2014 |
| Procedure |
percutaneous coronary intervention with stent implantation |
1 |
2018 |
| Device |
percutaneous coronary intervention with taxus stent |
1 |
2006 |
| Device |
percutaneous coronary stenting |
1 |
2005 |
| Procedure |
percutaneous transluminal angioplasty |
1 |
2006 |
| Procedure |
percuteneous coronary intervention |
1 |
2018 |
| Drug |
perflutren lipid microsphere injectable suspension |
1 |
2005 |
| Other |
perfusion cardiac magnetic resonance imaging |
1 |
2009 |
| Other |
perfusion cmr for detection of coronary artery disease |
1 |
2009 |
| Other |
periodized exercise training regime |
1 |
2017 |
| Procedure |
periodontal therapy |
1 |
2010 |
| Procedure |
periodontal treatment: srp |
1 |
2003 |
| Other |
peripheral muscle training |
1 |
2018 |
| Procedure |
peripheral nerve block |
1 |
2017 |
| Radiation |
peripheral quantitative computed tomography of the radius |
1 |
2013 |
| Device |
permanent polymer everolimus-eluting stent (xience, promus) |
1 |
2008 |
| Device |
permanent polymer limus-eluting stent |
1 |
2010 |
| Device |
permanent polymer rapamycin-eluting stent (cypher) |
1 |
2008 |
| Other |
personal health record |
1 |
2013 |
| Drug |
personalized dapt duration |
1 |
2019 |
| Behavioral |
personalized prevention messages |
1 |
2005 |
| Behavioral |
personalized reminders |
1 |
2019 |
| Other |
pet-mr imaging on biograph mmr scanner |
1 |
2014 |
| Other |
pet imaging |
1 |
2006 |
| Drug |
pet mpi |
1 |
2017 |
| Radiation |
pet scan |
1 |
2016 |
| Diagnostic Test |
pet stress test |
1 |
2019 |
| Device |
pet/ct |
1 |
2006 |
| Other |
pet/mr scan |
1 |
2016 |
| Drug |
pexelizumab in conjunction with cabg |
1 |
2004 |
| Behavioral |
pharmacist counselling session with a motivational interview |
1 |
2013 |
| Drug |
pharmacological stress agents |
1 |
2017 |
| Device |
phase signal recorder |
1 |
2016 |
| Other |
phcvrs intervention |
1 |
2013 |
| Behavioral |
physical activity |
1 |
2005 |
| Device |
physical activity monitors |
1 |
2010 |
| Procedure |
physician taken history |
1 |
2007 |
| Other |
physiological saline |
1 |
2018 |
| Device |
physiologically-guided strategy |
1 |
2017 |
| Other |
physiotherapy exercises |
1 |
2015 |
| Dietary Supplement |
phytosterol enhanced soy based beverage |
1 |
2009 |
| Other |
phytosterols |
1 |
2009 |
| Other |
phytosterols / ezetimibe |
1 |
2009 |
| Procedure |
picso |
1 |
2011 |
| Device |
piezoelectric ultrasonic scaler (frequency of 28-36 khz) |
1 |
2015 |
| Drug |
pioglitazone 15 mg tablet |
1 |
2016 |
| Drug |
pioglitazone 30 mg |
1 |
2011 |
| placebo |
placebo (for rvx000222) |
1 |
2015 |
| placebo |
placebo (for sarpogrelate) |
1 |
2014 |
| placebo |
placebo (saline) |
1 |
2009 |
| Drug |
placebo / aspirin |
1 |
2010 |
| Drug |
placebo / isosorbite mononitrate (ismn) |
1 |
2017 |
| placebo |
placebo 40 mg |
1 |
2006 |
| placebo |
placebo arm |
1 |
2010 |
| placebo |
placebo capsules |
1 |
2009 |
| placebo |
placebo colesevelam |
1 |
2008 |
| placebo |
placebo comparator: |
1 |
2008 |
| placebo |
placebo comparator: lactated ringer’s |
1 |
2012 |
| Device |
placebo comparator: lactated ringer’s/subject’s blood |
1 |
2012 |
| placebo |
placebo control |
1 |
2009 |
| placebo |
placebo for atorvastatin |
1 |
2019 |
| placebo |
placebo for clopidogrel |
1 |
2006 |
| placebo |
placebo for colestipol |
1 |
1999 |
| placebo |
placebo for ezetimibe |
1 |
2019 |
| placebo |
placebo for lovastatin |
1 |
1999 |
| placebo |
placebo for prasugrel |
1 |
2006 |
| placebo |
placebo influenza vaccine |
1 |
2006 |
| placebo |
placebo infusion |
1 |
2011 |
| placebo |
placebo injection |
1 |
2017 |
| placebo |
placebo intake |
1 |
2015 |
| placebo |
placebo iv |
1 |
2015 |
| placebo |
placebo juice |
1 |
2008 |
| placebo |
placebo matching azd5817 oral suspension |
1 |
2017 |
| placebo |
placebo niacin |
1 |
2008 |
| placebo |
placebo of isosorbide dinitrate |
1 |
2012 |
| placebo |
placebo of quick-acting heart reliever |
1 |
2012 |
| placebo |
placebo of sheng mai capsules |
1 |
2009 |
| placebo |
placebo of sheng mai capsules, |
1 |
2009 |
| placebo |
placebo of xuefu zhuyu capsules |
1 |
2009 |
| Drug |
placebo of xuefu zhuyu capsules/placebo of sheng mai capsules |
1 |
2009 |
| placebo |
placebo pills |
1 |
2018 |
| placebo |
placebo sc |
1 |
2015 |
| placebo |
placebo suspension |
1 |
2008 |
| placebo |
placebo tablet |
1 |
2012 |
| placebo |
placebo to match azd6140 |
1 |
2008 |
| placebo |
placebo to telcagepant |
1 |
2011 |
| placebo |
placebo, double |
1 |
2007 |
| Drug |
placebo/aspirin |
1 |
2009 |
| Drug |
placebo/sugar pill |
1 |
2005 |
| placebo |
placebo: diluent used to suspend auto-cd34 |
1 |
2012 |
| Biological |
placebo: diluent used to suspend auto-cd34/ cells |
1 |
2012 |
| Diagnostic Test |
platelet acetyl coenzyme a carboxylase analysis in cad |
1 |
2017 |
| Drug |
plavix |
1 |
2010 |
| Drug |
plavix (clopidogrel bisulfate) |
1 |
2009 |
| Drug |
plavixâ® |
1 |
2011 |
| Behavioral |
plus |
1 |
2014 |
| Device |
poba |
1 |
2010 |
| Genetic |
point-of-care genetic screening with subsequent prasugrel administration to cyp2c19*2 carriers |
1 |
2010 |
| Drug |
policosanol |
1 |
2011 |
| Drug |
policosanol/dual antiplatelet |
1 |
2011 |
| Device |
polymer-free amphilimus-eluting stents |
1 |
2017 |
| Device |
polymer-free des (drug eluting stent) |
1 |
2015 |
| Device |
polymer-free stent |
1 |
2016 |
| Device |
polymer-free, rapamycin-eluting stent |
1 |
2006 |
| Device |
polymer based zotarolimus-eluting stent (endeavor resolute) |
1 |
2008 |
| Drug |
pomwonderful juice |
1 |
2008 |
| Other |
position change applied at different times |
1 |
2018 |
| Procedure |
positron emission tomography: fdg viability imaging |
1 |
2006 |
| Behavioral |
post-operative cardiac rehabilitation |
1 |
2016 |
| Drug |
post-operative gabapentin analgesia |
1 |
2018 |
| Drug |
post-operative ondansetron anti-emesis |
1 |
2018 |
| Drug |
post-operative oral paracetamol analgesia |
1 |
2018 |
| Diagnostic Test |
post-pci coronary physiology measurements |
1 |
2017 |
| Dietary Supplement |
post cabg |
1 |
2014 |
| Behavioral |
postoperative cardiac rehabilitation |
1 |
2016 |
| Device |
powerassert rf wire in crossing coronary in-stent chronic total occlusions |
1 |
2010 |
| Drug |
ppc heparin |
1 |
2011 |
| Drug |
prasugrel 10mg |
1 |
2013 |
| Drug |
prasugrel 30 mg |
1 |
2014 |
| Drug |
prasugrel loading dose |
1 |
2012 |
| Drug |
prasugrel maintenance dose |
1 |
2012 |
| placebo |
prasugrel placebo |
1 |
2006 |
| Drug |
pravastatin 20 mg |
1 |
2014 |
| Behavioral |
pre-habilitation |
1 |
2018 |
| Dietary Supplement |
pre-operative carbohydrate preload drink |
1 |
2018 |
| Behavioral |
pre/post-operative cardiac rehabilitation |
1 |
2016 |
| Diagnostic Test |
pre/post-pci coronary physiology measurements |
1 |
2017 |
| Drug |
prednisone |
1 |
2006 |
| Drug |
pregrel (clopidogrel resinate) |
1 |
2009 |
| Drug |
pregrelâ® |
1 |
2011 |
| Drug |
premarin .625 mg daily |
1 |
2006 |
| Drug |
premarin .625 mg daily/medroxyprogesterone 2.5 mg daily |
1 |
2006 |
| Other |
preoperative coronary angiography |
1 |
2014 |
| Other |
preoperative exercise training |
1 |
2018 |
| Device |
presillion cobalt chromium stent |
1 |
2008 |
| Behavioral |
pressure pain sensitivity measure followed bu acupressure |
1 |
2012 |
| Device |
pressure wire certus, st. jude medical, usa |
1 |
2016 |
| Device |
prevena device (group a) |
1 |
2012 |
| Behavioral |
prevention consult |
1 |
2012 |
| Procedure |
previous coronary ct angiography on 2nd generation ct scanner |
1 |
2014 |
| Procedure |
primary pci with thrombectomy |
1 |
2011 |
| Procedure |
primary pci without thrombectomy |
1 |
2011 |
| Procedure |
primary percutaneous coronary intervention |
1 |
2013 |
| Device |
pro-kinetic energy stent |
1 |
2012 |
| Behavioral |
problem solving treatment in primary care (pst-pc) |
1 |
2015 |
| Drug |
probucol |
1 |
2011 |
| Device |
probucol-eluting stent (isar stent) |
1 |
2008 |
| Biological |
progenitors |
1 |
2013 |
| Drug |
progestins |
1 |
1999 |
| Drug |
proleukin |
1 |
2017 |
| Device |
promus |
1 |
2010 |
| Device |
promus coronary stent system |
1 |
2009 |
| Device |
promus des |
1 |
2017 |
| Device |
promus element (everolimus-eluting stent) |
1 |
2011 |
| Device |
promus element everolimus-eluting coronary stent system |
1 |
2011 |
| Device |
promus element plus |
1 |
2012 |
| Device |
promus element/coronary stent system |
1 |
2012 |
| Device |
promus elementâ„¢ |
1 |
2009 |
| Device |
promus(tm) element (tm) stent system |
1 |
2010 |
| Procedure |
prone imaging |
1 |
2015 |
| Drug |
propofol 1.0mcg |
1 |
2013 |
| Drug |
propofol 2.0mcg |
1 |
2013 |
| Drug |
propofol 3.0mcg |
1 |
2013 |
| Genetic |
prospective genotype testing |
1 |
2012 |
| Procedure |
provisional approach |
1 |
2013 |
| Procedure |
provisional t stenting |
1 |
2008 |
| Drug |
psychiatric treatment with escitalopram |
1 |
2019 |
| Drug |
psychiatric treatment with sertraline |
1 |
2019 |
| Behavioral |
psycho-educative component |
1 |
2013 |
| Behavioral |
psychodynamic motivation |
1 |
2011 |
| Behavioral |
psychodynamic motivation/training program (pmt) |
1 |
2011 |
| Other |
psychometric analysis |
1 |
2019 |
| Behavioral |
psychotherapy |
1 |
2008 |
| Other |
ptca |
1 |
2005 |
| Device |
ptca balloon catheter |
1 |
2009 |
| Device |
ptca of coronary de novo lesion pcb |
1 |
2019 |
| Device |
ptca of coronary de novo lesion scb |
1 |
2019 |
| Device |
ptca with stent placement |
1 |
2011 |
| Behavioral |
public education |
1 |
2019 |
| Behavioral |
public education/network construction |
1 |
2019 |
| Other |
pump-assisted cabg |
1 |
2018 |
| Procedure |
pump-assisted cabg. |
1 |
2018 |
| Device |
pvc chest tube |
1 |
2007 |
| Drug |
pycnogenol |
1 |
2008 |
| Other |
pyramid-training |
1 |
2011 |
| Other |
pyramid training |
1 |
2014 |
| Dietary Supplement |
q10-150 |
1 |
2013 |
| Dietary Supplement |
q10-300 |
1 |
2013 |
| Diagnostic Test |
qfr |
1 |
2018 |
| Diagnostic Test |
qfr-based diagnostic strategy |
1 |
2018 |
| Procedure |
qfr-guided cabg |
1 |
2018 |
| Device |
qfr-guided strategy |
1 |
2019 |
| Behavioral |
quality of life questionnaires |
1 |
2018 |
| Drug |
quercetin |
1 |
2019 |
| Other |
questionnaire |
1 |
2018 |
| Other |
questionnaire administration |
1 |
2014 |
| Drug |
quick-acting heart reliever |
1 |
2012 |
| Device |
quikclot radial pad |
1 |
2018 |
| Drug |
quinapril |
1 |
2005 |
| Device |
qvanteq bioactive coronary stent |
1 |
2014 |
| Device |
radi pressure wire (pressure wire assessment) |
1 |
2010 |
| Procedure |
radial approach |
1 |
2017 |
| Procedure |
radial artery |
1 |
2005 |
| Procedure |
radial artery graft |
1 |
2003 |
| Procedure |
radial artery/saphenous vein grafts randomized to either right coronary/left circumflex coronary artery territories |
1 |
2005 |
| Procedure |
radial technical |
1 |
2013 |
| Procedure |
radiofrequency ablation |
1 |
2017 |
| Drug |
radioisotope |
1 |
2014 |
| Radiation |
radiolabeled (99tc) ec-dg (ethylenedicysteine-deoxyglucose |
1 |
2013 |
| Drug |
ramipril |
1 |
2008 |
| Drug |
ramipril 5 mg |
1 |
2016 |
| Drug |
ramipril hoe498 |
1 |
2017 |
| Procedure |
randomised to guidelines group |
1 |
2011 |
| Procedure |
randomized left versus right radial artery approach |
1 |
2012 |
| Drug |
ranitidine |
1 |
2013 |
| placebo |
ranolazine placebo |
1 |
2011 |
| Device |
rapamycin-eluting stent |
1 |
2006 |
| Device |
rapamycin-eluting stent with biodegradable polymer |
1 |
2006 |
| Device |
rapamycin-eluting stent with permanent polymer |
1 |
2006 |
| Device |
rapamycin / probucol-eluting stent (isar stent) |
1 |
2008 |
| Device |
rapamycin target-eluting coronary stent system |
1 |
2016 |
| Device |
rapamycin target-eluting coronary stent systems (38mm) |
1 |
2016 |
| Device |
rapamycin/17beta estradiolvalerat-eluting stent |
1 |
2006 |
| Other |
rapid-vt software guided ablation |
1 |
2018 |
| Other |
rate of perceived exertion |
1 |
2012 |
| Radiation |
real-time 3-dimensional dynact |
1 |
2014 |
| Drug |
red yeast rice |
1 |
2006 |
| Procedure |
referral |
1 |
2003 |
| Procedure |
refill reminder postcard |
1 |
2005 |
| Drug |
reg1 |
1 |
2008 |
| Drug |
regadenoson (lexercise) |
1 |
2010 |
| Drug |
regadenoson (lexiscan) |
1 |
2010 |
| Drug |
regadenoson central - peripheral |
1 |
2012 |
| Drug |
regadenoson central -central |
1 |
2012 |
| Drug |
regadenoson mri |
1 |
2012 |
| Drug |
regadenoson mri myocardial blood flow |
1 |
2009 |
| Drug |
regadenoson myocardial perfusion imaging |
1 |
2009 |
| Drug |
regadenoson peripheral - central |
1 |
2012 |
| Drug |
regadenoson peripheral - peripheral |
1 |
2012 |
| Drug |
regular human insulin |
1 |
2015 |
| Other |
regular screening |
1 |
2018 |
| Other |
rehabilitation |
1 |
2017 |
| Behavioral |
rehabilitation at home |
1 |
2006 |
| Behavioral |
rehabilitation in institution |
1 |
2006 |
| Combination Product |
reimmugen |
1 |
2016 |
| Other |
relaxation music |
1 |
2013 |
| Behavioral |
reminder |
1 |
2003 |
| Procedure |
remote ischaemic preconditioning |
1 |
2010 |
| Other |
remote ischemic conditioning |
1 |
2013 |
| Procedure |
remote ischemic postconditioning |
1 |
2009 |
| Other |
removal of fentanyl from peri-procedural analgesia |
1 |
2016 |
| Other |
reports |
1 |
2009 |
| Other |
reports/notices |
1 |
2009 |
| Behavioral |
resilience, stress, |
1 |
2019 |
| Behavioral |
resilience, stress,/ethnicity (rise) |
1 |
2019 |
| Behavioral |
resistance training |
1 |
2016 |
| Device |
resmed s8 (auto-cpap) |
1 |
2007 |
| Device |
resolute integrity (zotarolimus-eluting stent) |
1 |
2011 |
| Device |
resolute integrity zotarolimus eluting stent |
1 |
2014 |
| Device |
resolute integrityâ„¢ zotarolimus-eluting coronary stent system(34 |
1 |
2017 |
| Device |
resolute integrityâ„¢ zotarolimus-eluting coronary stent system(34/38 mm) |
1 |
2017 |
| Device |
resolute onyx stent - 2.0 mm |
1 |
2015 |
| Device |
resolute onyx stent - 2.25 mm - 4.0 mm |
1 |
2015 |
| Device |
resolute stent treatment |
1 |
2012 |
| Device |
resolute zotarolimus-eluting coronary stent |
1 |
2008 |
| Device |
resolute zotarolimus-eluting coronary stent system |
1 |
2011 |
| Device |
resolute zotarolimus-eluting stent |
1 |
2015 |
| Other |
respiratory rehabilitation |
1 |
2018 |
| Other |
rest |
1 |
2016 |
| Other |
rest five hours |
1 |
2012 |
| Other |
rest three hours |
1 |
2012 |
| Drug |
resten-mp |
1 |
2005 |
| Dietary Supplement |
resveratrol (3, 4â´, 5 trihydroxystilbene) |
1 |
2014 |
| Genetic |
retrospective genotype testing |
1 |
2012 |
| Drug |
revacept 160 mg |
1 |
2017 |
| Drug |
revacept 80 mg |
1 |
2017 |
| Device |
revascularisation |
1 |
2013 |
| Procedure |
reverse tap |
1 |
2018 |
| Device |
rezolve stent |
1 |
2010 |
| Diagnostic Test |
rfr |
1 |
2020 |
| Procedure |
rfr guided cabg |
1 |
2020 |
| Device |
ric |
1 |
2018 |
| Drug |
rifabutin oral capsule |
1 |
2018 |
| Drug |
rifampicin |
1 |
2008 |
| Procedure |
right internal thoracic artery composite grafting |
1 |
2010 |
| Drug |
rilonacept |
1 |
2006 |
| Drug |
rimonabant (sr141716) |
1 |
2005 |
| Drug |
ringer’s solution |
1 |
2013 |
| Procedure |
ripple mapping guided ischaemic vt ablation |
1 |
2019 |
| Behavioral |
risk result |
1 |
2013 |
| Drug |
rituximab injection |
1 |
2017 |
| Drug |
rivaroxaban (xarelto, bay59-7939) |
1 |
2011 |
| Drug |
rivaroxaban (xarelto, bay59-7939)/ufh |
1 |
2011 |
| Drug |
rivaroxaban 2.5 mg oral tablet |
1 |
2019 |
| Drug |
rivaroxaban 2.5mg tablet |
1 |
2018 |
| Drug |
ro4905417 |
1 |
2010 |
| Procedure |
robot assisted percutaneous cardiovascular intervention |
1 |
2020 |
| Procedure |
robotic-assisted coronary surgical revascularization |
1 |
2006 |
| Behavioral |
role modeling |
1 |
2006 |
| Other |
room light |
1 |
2015 |
| Device |
root planing |
1 |
2012 |
| Drug |
ropivacaine |
1 |
2019 |
| Drug |
rosiglitazone (4 mg) |
1 |
2012 |
| Drug |
rosiglitazone (4 mg)/day |
1 |
2012 |
| Drug |
rosuvastatin-esomeprazole |
1 |
2009 |
| Drug |
rosuvastatin-omeprazole |
1 |
2009 |
| Drug |
rosuvastatin-pantoprazole |
1 |
2009 |
| Drug |
rosuvastatin-ranitidine |
1 |
2009 |
| Drug |
rosuvastatin (crestor) |
1 |
2007 |
| Drug |
rosuvastatin 10 mg |
1 |
2017 |
| Drug |
rosuvastatin 10 mg/ezetimibe 10 mg orally once a day |
1 |
2017 |
| Drug |
rosuvastatin 10mg |
1 |
2018 |
| Drug |
rosuvastatin 20 mg orally once a day |
1 |
2017 |
| Drug |
rosuvastatin alone |
1 |
2014 |
| Drug |
rosuvastatin calcium 20 mg oral tablet |
1 |
2016 |
| Drug |
rosuvastatin calcium 40mg |
1 |
2009 |
| Drug |
rosuvastatin tablet |
1 |
2016 |
| Drug |
rosuvastatin/atorvastatin/simvastatin/clopidogrel |
1 |
2005 |
| Drug |
rosuvastatin/fenofibrate |
1 |
2014 |
| Procedure |
rotablation |
1 |
2019 |
| Device |
rotablator |
1 |
2013 |
| Device |
rotablator rotational atherectomy system |
1 |
2016 |
| Device |
rotational atherectomy by rotablator |
1 |
2016 |
| Drug |
routine dual antiplatelet |
1 |
2011 |
| Device |
routine measurement of ffr |
1 |
2016 |
| Other |
routine referral (at 5 weeks) |
1 |
2012 |
| Diagnostic Test |
routine stress testing |
1 |
2017 |
| Radiation |
rubidium pet |
1 |
2012 |
| Device |
safeseal(tm) hemostasis patch |
1 |
2007 |
| Other |
safflower oil |
1 |
2012 |
| Drug |
salsalate |
1 |
2008 |
| Procedure |
saphenous vein composite grafting |
1 |
2010 |
| Procedure |
saphenous vein graft |
1 |
2003 |
| Procedure |
saphenous vein grafts randomized to either right coronary |
1 |
2005 |
| Device |
sapphire ii pro |
1 |
2017 |
| Drug |
sar247799 |
1 |
2018 |
| Device |
savr |
1 |
2018 |
| Drug |
saxagliptin |
1 |
2012 |
| Drug |
sb-480848 |
1 |
2005 |
| Drug |
sb-681323 |
1 |
2006 |
| Device |
scaffold |
1 |
2014 |
| Device |
scb ptca |
1 |
2019 |
| Behavioral |
schultz autogenic training |
1 |
2020 |
| Device |
scintigraphic imaging |
1 |
2015 |
| Device |
scoreflex nc scoring ptca catheter |
1 |
2018 |
| Device |
scoring balloon |
1 |
2015 |
| Device |
scoring ptca balloon (nse alpha) |
1 |
2018 |
| Other |
secondary prevention |
1 |
2014 |
| Behavioral |
secondary prevention program for coronary heart disease |
1 |
2005 |
| Other |
secondary prevention/cardiac rehabilitation clinic |
1 |
2014 |
| Device |
secss |
1 |
2010 |
| Behavioral |
sedentary prompts from a vtap device |
1 |
2016 |
| Biological |
selected cd 133 |
1 |
2008 |
| Biological |
selected cd 133/ cells |
1 |
2008 |
| Drug |
selected cell product |
1 |
2016 |
| Drug |
selected form (form 2 - 5) of azd5718 tablets |
1 |
2018 |
| Other |
selective screening |
1 |
2014 |
| Behavioral |
self-management intervention |
1 |
2013 |
| Drug |
semaglutide 2 mg |
1 |
2019 |
| Drug |
semaglutide 2 mg/1.5 ml subcutaneous solution |
1 |
2019 |
| Device |
sequent please drug eluting balloon catheter with paclitaxel |
1 |
2019 |
| Device |
sequent(r) please coated balloon |
1 |
2011 |
| Device |
sequentâ® please paclitaxel-coated balloon |
1 |
2014 |
| Drug |
serelaxin |
1 |
2013 |
| Device |
ses |
1 |
2008 |
| Drug |
sestamibi. reconstitution with sodium pertechnetate (99mtc) |
1 |
2011 |
| Drug |
sevoflurane 1 |
1 |
2015 |
| Drug |
sevoflurane 2 |
1 |
2015 |
| Other |
sexual rehabilitation |
1 |
2013 |
| Other |
sham cardiac shock wave (control group) |
1 |
2017 |
| Other |
sham comparator |
1 |
2017 |
| Behavioral |
sham comparator: neutral writing |
1 |
2010 |
| Other |
sham controll |
1 |
2019 |
| Device |
sham operation |
1 |
2017 |
| Procedure |
sham transcutaneous acupoint electrical stimulation |
1 |
2018 |
| Behavioral |
shared care model |
1 |
2012 |
| Drug |
sheng mai capsules |
1 |
2009 |
| Drug |
sheng mai capsules/placebo of xuefu zhuyu capsules |
1 |
2009 |
| Device |
shockwave coronary rx lithoplastyâ® system |
1 |
2015 |
| Other |
short |
1 |
2018 |
| Procedure |
short introducer sheath |
1 |
2019 |
| Other |
short/fast step test with measurement of pulmonary gas exchange |
1 |
2018 |
| Other |
short/fast step test without measurement of pulmonary gas exchange |
1 |
2018 |
| Other |
significant extracoronary arterial stenoses in all arterial beds |
1 |
2007 |
| Drug |
sildenafil |
1 |
2018 |
| Drug |
simivastatin |
1 |
2019 |
| Drug |
simvastatin ( |
1 |
2007 |
| Drug |
simvastatin (/) ezetimibe |
1 |
2007 |
| Drug |
simvastatin 10 |
1 |
2007 |
| Drug |
simvastatin 20mg |
1 |
2007 |
| Drug |
simvastatin 20mg/ezetimibe 10mg |
1 |
2007 |
| Drug |
simvastatin 80mg |
1 |
2007 |
| placebo |
simvastatin placebo |
1 |
2007 |
| Drug |
single antiplatelet agents |
1 |
2018 |
| Procedure |
single arterial graft |
1 |
2017 |
| Drug |
single dose polycap |
1 |
2011 |
| Procedure |
single photon emission computed tomography (spect) myocardial perfusion imaging (mpi) |
1 |
2012 |
| Device |
sirolimus-eluting coronary stent (cypher) |
1 |
2008 |
| Device |
sirolimus-eluting stent for short lesion |
1 |
2010 |
| Device |
sirolimus-eluting stent system |
1 |
2015 |
| Device |
sirolimus-eluting stent with a bioresorbable polymer (orsiro) |
1 |
2011 |
| Device |
sirolimus-eluting stent, zotarolimus-eluting stent |
1 |
2007 |
| Device |
sirolimus-eluting, heparin-coated cocr balloon-expandable stent |
1 |
2005 |
| Device |
sirolimus coated bx velocity stent - fast release |
1 |
2005 |
| Device |
sirolimus coated bx velocity stent - slow release |
1 |
2005 |
| Device |
sirolimus coated bx velocityâ„¢ |
1 |
2005 |
| Procedure |
sirolimus drug-eluting stent implantation via provisional t stenting |
1 |
2016 |
| Procedure |
sirolimus drug-eluting stent via active transfer of plaque |
1 |
2016 |
| Device |
sirolimus eluting coronary stent |
1 |
2014 |
| Device |
sirolimus eluting coronary stent system (biomime) |
1 |
2012 |
| Device |
sirolimus eluting cypher select(tm) |
1 |
2005 |
| Device |
sirolimus eluting drug stent |
1 |
2014 |
| Device |
sirolimus eluting stent inspiron |
1 |
2015 |
| Device |
sirolimus target eluting bioresorbable vascular scaffold |
1 |
2016 |
| Device |
siso model-based predictive closed-loop system |
1 |
2008 |
| Drug |
sitagliptin/acarbose |
1 |
2013 |
| Procedure |
skeletonization of the internal thoracic artery |
1 |
2005 |
| Procedure |
skeletonized lima |
1 |
2018 |
| Other |
skin wetting |
1 |
2019 |
| Other |
sleep education |
1 |
2010 |
| Other |
slow-paced walking |
1 |
2015 |
| Other |
smartphone |
1 |
2012 |
| Behavioral |
smartphone application |
1 |
2019 |
| Diagnostic Test |
smartphone assessment |
1 |
2019 |
| Behavioral |
smbg |
1 |
2013 |
| Behavioral |
smoking cessation counseling |
1 |
2017 |
| Behavioral |
smt-enhanced cardiac rehabilitation |
1 |
2009 |
| Diagnostic Test |
soc cardiovascular evaluation |
1 |
2019 |
| Behavioral |
soccer |
1 |
2012 |
| Other |
sodium chloride |
1 |
2011 |
| Dietary Supplement |
sodium nitrate |
1 |
2011 |
| Drug |
sodium nitrite |
1 |
2017 |
| Drug |
sodium valproate |
1 |
2018 |
| Drug |
somatotropin |
1 |
2007 |
| Drug |
somatropin |
1 |
2020 |
| Device |
somvc001 vascular conduit solution |
1 |
2014 |
| Device |
sonolysis |
1 |
2014 |
| Other |
spect-mpi |
1 |
2015 |
| Radiation |
spect imaging |
1 |
2016 |
| Drug |
spect mpi |
1 |
2017 |
| Procedure |
spinal analgesia |
1 |
2005 |
| Procedure |
spinal analgesia/anesthesia for coronary artery surgery |
1 |
2005 |
| Device |
sprinter legend 1.25mm balloon catheter |
1 |
2009 |
| Biological |
stage 1-high dose vm202ry |
1 |
2017 |
| Biological |
stage 1-low dose vm202ry |
1 |
2017 |
| Biological |
stage 1-middle dose vm202ry |
1 |
2017 |
| Biological |
stage 2-high dose vm202ry |
1 |
2017 |
| Biological |
stage 2-low dose vm202ry |
1 |
2017 |
| placebo |
stage 2-placebo |
1 |
2017 |
| Procedure |
staged complete pci |
1 |
2017 |
| Device |
standard 6- french radial sheath |
1 |
2014 |
| Other |
standard cardiac imaging |
1 |
2010 |
| Behavioral |
standard cardiac rehabilitation |
1 |
2009 |
| Other |
standard cardiac workup |
1 |
2014 |
| Device |
standard catheter |
1 |
2016 |
| Other |
standard control |
1 |
2011 |
| Drug |
standard dapt |
1 |
2019 |
| Drug |
standard dapt duration |
1 |
2019 |
| Other |
standard discharge |
1 |
2013 |
| Device |
standard dose non-contrast enhanced ct |
1 |
2015 |
| Drug |
standard dose rosuvastatin |
1 |
2017 |
| Device |
standard freebreathing spect-mpi |
1 |
2015 |
| Drug |
standard insulin treatment |
1 |
2014 |
| Device |
standard intra-venous (iv) infusion |
1 |
2015 |
| Other |
standard of care for heart failure |
1 |
2013 |
| Other |
standard of care for heart failure/coronary artery disease |
1 |
2013 |
| Other |
standard of care heparin-dosed saline |
1 |
2014 |
| Drug |
standard of care lipid therapy |
1 |
2012 |
| Other |
standard outpatient observation |
1 |
2017 |
| Device |
standard strategy |
1 |
2018 |
| Other |
standard technique |
1 |
2012 |
| Behavioral |
standard therapeutic support |
1 |
2019 |
| Drug |
statin recapture therapy |
1 |
2012 |
| Drug |
statins, ezetimibe |
1 |
2007 |
| Device |
statseal |
1 |
2017 |
| Device |
statseal with tr band |
1 |
2019 |
| Biological |
stem cell |
1 |
2005 |
| Device |
stem cell injection |
1 |
2006 |
| Procedure |
stem cell mobilization |
1 |
2002 |
| Biological |
stem cell therapy |
1 |
2006 |
| Device |
stent implantation |
1 |
2010 |
| Procedure |
stent technique: provisional fkbt |
1 |
2010 |
| Procedure |
stent technique: routine fkbt |
1 |
2010 |
| Device |
stent, medronic resolute integrity |
1 |
2015 |
| Device |
stent/scaffold |
1 |
2014 |
| Procedure |
stenting/minimally invasive bypass surgery |
1 |
2005 |
| Other |
stenting/omt |
1 |
2010 |
| Behavioral |
stepping up to health |
1 |
2008 |
| Device |
sternalock blue closure system |
1 |
2013 |
| Other |
strength training |
1 |
2013 |
| Behavioral |
strength training intervention |
1 |
2005 |
| Procedure |
stress |
1 |
2005 |
| Procedure |
stress-echocardiography |
1 |
2008 |
| Procedure |
stress echocardiography with dobutamine |
1 |
1999 |
| Behavioral |
stress management |
1 |
2005 |
| Other |
stress mpi spect |
1 |
2011 |
| Procedure |
stress nuclear myocardial perfusion imaging |
1 |
2008 |
| Device |
stress single photon emission computed tomography |
1 |
2014 |
| Device |
study group |
1 |
2017 |
| Device |
subgingival scaling |
1 |
2012 |
| Device |
subgingival scaling/root planing |
1 |
2012 |
| Device |
subject’s blood |
1 |
2012 |
| Device |
subjects receiving desyne novolimus eluting css |
1 |
2013 |
| Behavioral |
subsequent lifestyle modifications |
1 |
2011 |
| Procedure |
substrate modification |
1 |
2009 |
| Drug |
sugammadex |
1 |
2019 |
| Drug |
sulfasalazine |
1 |
2007 |
| Device |
super high-pressure nc ptca balloon (opn nc) |
1 |
2018 |
| Behavioral |
supervised exercise on a stationary bicycle, 3-5 days a week |
1 |
2005 |
| Other |
supervised physical exercise training x2 weekly for 8 weeks |
1 |
2012 |
| Other |
supervised physical exercise training x3 weekly for 12 weeks |
1 |
2012 |
| Dietary Supplement |
supplement |
1 |
2015 |
| Dietary Supplement |
supplement post cabg |
1 |
2014 |
| Dietary Supplement |
supplement pre |
1 |
2014 |
| Dietary Supplement |
supplement pre cabg |
1 |
2014 |
| Dietary Supplement |
supplement pre/post cabg |
1 |
2014 |
| Dietary Supplement |
supplement/placebo intake |
1 |
2015 |
| Drug |
supplemental insulin (insulin aspart) |
1 |
2015 |
| Drug |
supplemental insulin (insulin lispro) |
1 |
2015 |
| Other |
supplemental oxygen |
1 |
2010 |
| Drug |
supplementation, food |
1 |
1999 |
| Behavioral |
support programme |
1 |
2005 |
| Behavioral |
supportive therapy |
1 |
2011 |
| Device |
supralimus-coreâ„¢ |
1 |
2008 |
| Device |
supralimus-coreâ„¢ sirolimus eluting coronary stent |
1 |
2010 |
| Device |
supralimusâ® sirolimus-eluting coronary stent |
1 |
2011 |
| Drug |
suprane (desflurane), baxter |
1 |
2007 |
| Device |
surveillance arm |
1 |
2010 |
| Device |
suture wire |
1 |
2013 |
| Drug |
suved |
1 |
2016 |
| Other |
symptom-limited exercise |
1 |
2009 |
| Device |
synergy 48 mm |
1 |
2017 |
| Device |
synergy des implantation during coronary angioplasty |
1 |
2018 |
| Device |
synergy investigational device |
1 |
2013 |
| Device |
synergy stent system |
1 |
2015 |
| Device |
synergyâ„¢ stent |
1 |
2017 |
| Behavioral |
systematic education in the reduction of the risk estimate to cardiovascular events |
1 |
2008 |
| Behavioral |
systemchange |
1 |
2014 |
| Procedure |
szabo t-stenting technique |
1 |
2018 |
| Procedure |
t-graft |
1 |
2010 |
| Procedure |
t-provisional stenting |
1 |
2016 |
| Procedure |
t-stenting technique |
1 |
2018 |
| Other |
tai chi exercises |
1 |
2019 |
| Behavioral |
talking rx |
1 |
2015 |
| Drug |
tamsulosin oral capsule |
1 |
2019 |
| Drug |
targeted ldl-c goal statin |
1 |
2015 |
| Device |
tavi |
1 |
2018 |
| Device |
taxus |
1 |
2009 |
| Device |
taxus elementâ„¢ paclitaxel-eluting stent system |
1 |
2015 |
| Device |
taxus express 2â„¢ |
1 |
2007 |
| Device |
taxus express paclitaxel-eluting coronary stent system |
1 |
2006 |
| Device |
taxus libert㨠|
1 |
2008 |
| Device |
taxus libertã¨â„¢ paclitaxel drug-eluting stent |
1 |
2008 |
| Device |
taxus libertã© stent system |
1 |
2006 |
| Device |
taxus libertã©â„¢-sr |
1 |
2006 |
| Device |
taxus liberte |
1 |
2007 |
| Device |
taxus liberte paclitaxel-eluting coronary stent system |
1 |
2011 |
| Device |
taxus paclitaxel-eluting stent |
1 |
2005 |
| Device |
taxus stent/cypher stent |
1 |
2006 |
| Device |
taxusâ„¢ element long stent |
1 |
2013 |
| Device |
taxusâ„¢ express2 |
1 |
2006 |
| Device |
taxusâ„¢ express2â„¢ paclitaxel eluting coronary stent system |
1 |
2005 |
| Device |
taxusâ„¢ libertã¨â„¢ des |
1 |
2008 |
| Device |
taxusâ® express2â„¢ paclitaxel eluting coronary stent |
1 |
2005 |
| Device |
taxusâ® libertã©â„¢ |
1 |
2010 |
| Device |
taxusâ® libertã©â„¢ paclitaxel eluting coronary stent system |
1 |
2007 |
| Device |
tcd-10023 drug eluting stent |
1 |
2013 |
| placebo |
tcm granule placebo |
1 |
2011 |
| Drug |
tcm granule placebo/western basis treatment |
1 |
2011 |
| placebo |
tcm granules placebo |
1 |
2011 |
| Radiation |
technetium |
1 |
2009 |
| Radiation |
technetium tc99m sestamibi |
1 |
2011 |
| Radiation |
technetium tc99m sestamibi /technetium tc99m tetrafosmin |
1 |
2011 |
| Radiation |
technetium tc99m tetrafosmin |
1 |
2011 |
| Drug |
technetium tc99m tetrofosmin injections |
1 |
2006 |
| Other |
tee measurement |
1 |
2016 |
| Drug |
telcagepant |
1 |
2011 |
| Behavioral |
tele cardiac rehabilitation |
1 |
2017 |
| Other |
telehealth |
1 |
2020 |
| Other |
telemonitoring |
1 |
2017 |
| Behavioral |
telephone-based physical activity counseling program |
1 |
2005 |
| Behavioral |
telephone based peer support |
1 |
2014 |
| Behavioral |
telephone follow up |
1 |
2011 |
| Behavioral |
telephone interview |
1 |
2014 |
| Drug |
telmisartan |
1 |
2008 |
| Drug |
telmisartan 40 mg |
1 |
2006 |
| Drug |
telmisartan, bisoprolol |
1 |
2007 |
| Device |
temporary spinal cord stimulation |
1 |
2018 |
| Drug |
testosterone undecanoate |
1 |
2005 |
| Other |
tetracosactin |
1 |
2006 |
| Drug |
tetraspan |
1 |
2011 |
| Drug |
tetrofosmin) |
1 |
2011 |
| Behavioral |
text message |
1 |
2017 |
| Behavioral |
text message reminders |
1 |
2017 |
| Drug |
thallous chloride t1-201 |
1 |
2006 |
| Other |
the mediterranean-like diet |
1 |
2017 |
| Device |
the synergyâ® stent |
1 |
2018 |
| Behavioral |
therapeutic education |
1 |
2013 |
| Drug |
thienopyridine for 3 months |
1 |
2012 |
| Drug |
thienopyridine therapy |
1 |
2010 |
| Drug |
thiopentone |
1 |
2011 |
| Procedure |
thrombus aspiration catheter |
1 |
2011 |
| Drug |
ticagrelor / aspirin |
1 |
2013 |
| Drug |
ticagrelor 270mg |
1 |
2013 |
| Drug |
ticagrelor 360mg |
1 |
2013 |
| Drug |
ticagrelor 60 |
1 |
2014 |
| Drug |
ticagrelor 60 mg |
1 |
2017 |
| Drug |
ticagrelor 90 |
1 |
2014 |
| Drug |
ticagrelor loading dose |
1 |
2014 |
| Drug |
ticagrelor tablets |
1 |
2007 |
| Drug |
ticagrelor/aspirin |
1 |
2020 |
| Device |
tiger cardiac catheter |
1 |
2017 |
| Behavioral |
timing of initiation of cardiac rehabilitation |
1 |
2017 |
| Drug |
tissue plasminogen activator |
1 |
1999 |
| Device |
tivoli |
1 |
2015 |
| Drug |
tongxinluo |
1 |
2012 |
| Drug |
topical lidocaine |
1 |
2016 |
| Drug |
topical nitroglycerine |
1 |
2016 |
| Other |
topical treatment |
1 |
2009 |
| Drug |
torcetrapib |
1 |
2005 |
| Drug |
torcetrapib/atorvastatin |
1 |
2005 |
| Drug |
tp10 |
1 |
2004 |
| Device |
tr band |
1 |
2017 |
| Device |
tr band only |
1 |
2019 |
| Procedure |
track light |
1 |
2010 |
| Procedure |
traditional acupuncture |
1 |
2007 |
| Procedure |
traditional cardiac rehabilitation |
1 |
2013 |
| Behavioral |
traditional training |
1 |
2014 |
| Other |
training / glitazon |
1 |
2007 |
| Other |
training / metformin |
1 |
2007 |
| Behavioral |
training program (pmt) |
1 |
2011 |
| Drug |
trandolapril |
1 |
2005 |
| Other |
trans-femoral |
1 |
2013 |
| Other |
trans-radial |
1 |
2013 |
| Dietary Supplement |
trans-resveratrol |
1 |
2018 |
| Procedure |
transcutaneous acupoint electrical stimulation |
1 |
2018 |
| Drug |
transdermal nicotine patch |
1 |
2009 |
| Biological |
transepicardial with transseptal cd 133 |
1 |
2016 |
| Biological |
transepicardial with transseptal cd 133/ implantation |
1 |
2016 |
| Procedure |
transfemoral |
1 |
2016 |
| Procedure |
transfemoral coronary angiography |
1 |
2013 |
| Procedure |
transfemoral coronary angiography/intervention |
1 |
2013 |
| Other |
transition to unsupervised phase |
1 |
2019 |
| Procedure |
transplantation of iron-bearing nanoparticles |
1 |
2010 |
| Procedure |
transplantation of nanoparticles |
1 |
2010 |
| Procedure |
transradial |
1 |
2016 |
| Procedure |
transradial coronary angiography |
1 |
2013 |
| Procedure |
transradial coronary angiography/intervention |
1 |
2013 |
| Other |
transtheoretical model-based (ttm - based) intervention |
1 |
2019 |
| Other |
transtheoretical model-based (ttm - based) intervention/motivational interviewing (mi) |
1 |
2019 |
| Device |
transthoracic echocardiography |
1 |
2015 |
| Device |
transthoracic echocardiography imaging |
1 |
2018 |
| Other |
treadmill aerobic exercise |
1 |
2017 |
| Other |
treadmill aerobic exercise in orthostatic position |
1 |
2017 |
| Other |
treadmill aerobic exercise in supine position |
1 |
2017 |
| Other |
treadmill aerobic exercise/water intake in orthostatic position |
1 |
2017 |
| Other |
treadmill aerobic exercise/water intake in supine position |
1 |
2017 |
| Procedure |
treadmill exercise test |
1 |
2003 |
| Drug |
treatment a |
1 |
2019 |
| Other |
treatment as usual (tau) |
1 |
2011 |
| Drug |
treatment b |
1 |
2019 |
| Drug |
treatment c |
1 |
2019 |
| Biological |
treatment group |
1 |
2007 |
| Device |
tri staple technology stapler |
1 |
2009 |
| Device |
trimaxx coronary stent placement |
1 |
2008 |
| Drug |
trimetazidine |
1 |
2006 |
| Device |
truefidelity |
1 |
2019 |
| Procedure |
trust technique |
1 |
2017 |
| Device |
tryton |
1 |
2010 |
| Device |
tryton side branch stent with main branch des |
1 |
2010 |
| Behavioral |
tulppa rehabilitation |
1 |
2018 |
| Procedure |
turp |
1 |
2019 |
| Drug |
ufh |
1 |
2011 |
| Device |
ultimaster with 6 to 12 months dapt |
1 |
2015 |
| Device |
ultimasterâ® drug-eluting stent |
1 |
2016 |
| Diagnostic Test |
ultra low-dose ctac |
1 |
2018 |
| Device |
ultra low dose non-contrast enhanced ct |
1 |
2015 |
| Other |
ultrasound guided left stellate ganglion block |
1 |
2020 |
| Drug |
un-fractionated heparin |
1 |
2005 |
| Device |
uncoated bx velocity stent |
1 |
2005 |
| Procedure |
undersizing mitral annuloplasty |
1 |
2017 |
| Other |
upright position |
1 |
2010 |
| Drug |
urokinase |
1 |
2012 |
| Device |
use of bioresorbable vascular scaffolds |
1 |
2014 |
| Behavioral |
use of healthpals (telemedicine supported by digital health platform) |
1 |
2017 |
| Other |
use of hearthab application followed by usual care |
1 |
2017 |
| Procedure |
use of radial artery for access for a coronary angiography |
1 |
2019 |
| Procedure |
use of radial artery for access for a coronary angiography/intervention |
1 |
2019 |
| Combination Product |
uspio labeled msc injection |
1 |
2018 |
| Other |
usual cardiological care |
1 |
2008 |
| Other |
usual care followed by the use of hearthab application |
1 |
2017 |
| Other |
usual care group |
1 |
2018 |
| Behavioral |
usual care treatment |
1 |
2009 |
| Other |
usual coverage |
1 |
2007 |
| Behavioral |
usual text messages |
1 |
2019 |
| Device |
uvb phototherapy |
1 |
2009 |
| Other |
valve repair procedure with cabg. |
1 |
2018 |
| Other |
valve repair procedure without cabg. |
1 |
2018 |
| Drug |
vancomycin |
1 |
2013 |
| Drug |
varenicline |
1 |
2009 |
| Drug |
varespladib (a-002) |
1 |
2007 |
| Drug |
vascepa |
1 |
2016 |
| Behavioral |
vascular access decision aid |
1 |
2009 |
| Device |
vascular access site closure (7f ensure) |
1 |
2007 |
| Device |
vascular closure device |
1 |
2006 |
| Device |
vascular compression device- radar tm-short clamp time |
1 |
2014 |
| Device |
vascular compression device radar tm-long clamp time |
1 |
2014 |
| Other |
vegetarian diet followed by meat diet |
1 |
2016 |
| Other |
vegetarian diet followed by meat diet/vice versa |
1 |
2016 |
| Genetic |
vegf-a165 plasmid |
1 |
2005 |
| Biological |
vegf-d gene transfer |
1 |
2009 |
| Procedure |
vein harvest |
1 |
2005 |
| Other |
venous blood sampling |
1 |
2013 |
| Other |
ventilatory muscle training (tremven) |
1 |
2017 |
| Drug |
verapamil sr |
1 |
2005 |
| Drug |
verapamil sr/trandolapril/hydrochlorothiazide (hctz) |
1 |
2005 |
| Drug |
vericiguat (bay1021189) / isosorbite mononitrate |
1 |
2017 |
| Device |
verifynow |
1 |
2009 |
| Drug |
very-short dapt less than 1 month after pci |
1 |
2019 |
| Device |
vest |
1 |
2017 |
| Device |
vest external support |
1 |
2015 |
| Behavioral |
vhs |
1 |
2010 |
| Drug |
via-2291 |
1 |
2006 |
| Drug |
vicagrel 5mg |
1 |
2018 |
| Drug |
vicagrel 6mg |
1 |
2018 |
| Drug |
vicagrel 7.5mg |
1 |
2018 |
| Other |
vice versa |
1 |
2016 |
| Behavioral |
video decision aid |
1 |
2016 |
| Drug |
vildagliptin 50 mg oral tablet |
1 |
2018 |
| Behavioral |
virtual cardiac rehabilitation program |
1 |
2018 |
| Other |
virtual tour in coronary computed tomography - 360â° counselling environment |
1 |
2018 |
| Drug |
vitamin b12/folic acid |
1 |
2008 |
| Drug |
vitamin b6 |
1 |
1999 |
| Drug |
vitamin b6 (pyridoxine) |
1 |
2006 |
| Drug |
vitamin d3 50000 unt oral capsule |
1 |
2018 |
| Biological |
vm202ry |
1 |
2011 |
| Drug |
volatile anesthetic |
1 |
2011 |
| Drug |
volume replacement |
1 |
2010 |
| Drug |
vorapaxar |
1 |
2017 |
| Drug |
vorapaxar, aspirin, |
1 |
2017 |
| Drug |
vorapaxar, aspirin,/clopidogrel |
1 |
2017 |
| Drug |
vorapaxar/aspirin |
1 |
2017 |
| Drug |
vorapaxar/clopidogrel |
1 |
2017 |
| Procedure |
vt ablation |
1 |
2009 |
| Behavioral |
walking |
1 |
2013 |
| Other |
walking programme |
1 |
2016 |
| Other |
water-based exercise training |
1 |
2016 |
| Other |
water intake in orthostatic position |
1 |
2017 |
| Other |
water intake in supine position |
1 |
2017 |
| Drug |
water pill daily |
1 |
2005 |
| Behavioral |
web-based prevention program |
1 |
2019 |
| Other |
website |
1 |
2017 |
| Other |
weight-loss compliance |
1 |
2018 |
| Other |
weight loss |
1 |
2012 |
| Dietary Supplement |
weight loss treatment |
1 |
2012 |
| Behavioral |
weight reduction |
1 |
2007 |
| Drug |
western basis treatment |
1 |
2011 |
| Dietary Supplement |
wheat bran |
1 |
2018 |
| Device |
with stent |
1 |
2005 |
| Procedure |
without kissing balloon angioplasty “leave alone” |
1 |
2008 |
| Behavioral |
women@heart program |
1 |
2017 |
| Other |
worksheet to facilitate goal-setting |
1 |
2009 |
| Other |
worksheet to facilitate goal-setting/action plans |
1 |
2009 |
| Other |
x-ray coronary angiography |
1 |
2012 |
| Drug |
xenon/propofol |
1 |
2013 |
| Device |
xience coronary artery stent |
1 |
2016 |
| Device |
xience des |
1 |
2015 |
| Device |
xience prime |
1 |
2012 |
| Device |
xience prime des |
1 |
2012 |
| Device |
xience prime eecss |
1 |
2014 |
| Device |
xience prime everolimus-eluting stent system |
1 |
2015 |
| Device |
xience prime long lesion (ll) |
1 |
2009 |
| Device |
xience prime sv eecss |
1 |
2010 |
| Device |
xience primeâ® |
1 |
2013 |
| Device |
xience primeâ®/xience xpeditionâ„¢ |
1 |
2013 |
| Device |
xience v (everolimus-eluting stent) |
1 |
2010 |
| Device |
xience v everolimus eluting coronary stent system (xience v eecss) |
1 |
2010 |
| Device |
xience vâ® eecss |
1 |
2010 |
| Device |
xience vâ® everolimus eluting coronary stent system |
1 |
2007 |
| Device |
xience xpedition everolimus eluting stent |
1 |
2014 |
| Device |
xience xpeditionâ„¢ |
1 |
2013 |
| Device |
xience/promus des |
1 |
2017 |
| Device |
xienceâ„¢ |
1 |
2013 |
| Device |
xlimus |
1 |
2015 |
| Device |
xlimus des implantation during coronary angioplasty |
1 |
2018 |
| Drug |
xuefu-zhuyu capsule |
1 |
2019 |
| Drug |
xuefu zhuyu capsules |
1 |
2009 |
| Drug |
xuefu zhuyu capsules/placebo of sheng mai capsules, |
1 |
2009 |
| Procedure |
y-graft |
1 |
2018 |
| Drug |
yangxinshi pill |
1 |
2018 |
| Device |
yinyi stent |
1 |
2011 |
| Device |
yukon choice stent system |
1 |
2006 |
| Device |
zes resolute (endeavor resolute) |
1 |
2010 |
| Drug |
zetia [ezetimibe] |
1 |
2010 |
| Device |
zotarolimus-eluting stent for acs |
1 |
2010 |
| Device |
zotarolimus-eluting stent for acs/dm |
1 |
2010 |
| Device |
zotarolimus eluting stent (endeavor resoulte - zes resolute) |
1 |
2009 |